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Abstract
The number of people requiring an organ transplant in the United States has
increased considerably over the past 25 years, but the number of organ donations has
stagnated; over 8,000 people now die annually while awaiting a transplant or become too
sick to receive one. Tissue engineering (TE), the design and production of artificial
tissues and organs in vitro, has been proposed to alleviate this problem. Though synthetic
polymers offer tunable mechanical and biochemical properties, natural biomaterials have
recently garnered attention in TE for their high degree of biocompatibility and ability to
direct cell proliferation and constructive tissue remodeling. Yet scaffold processing
remains challenging and a need for novel treatment and fabrication methods still exists.
One underexplored method for creating TE scaffolds is treatment with
supercritical fluids (SCFs). SCFs are appealing for treating biomaterials because of their
desirable solvent properties; liquid-like densities and gas-like viscosities allow
supercritical fluids to wet and penetrate matrices easily without damaging surface tension
effects. Supercritical carbon dioxide (scCO2) is of particular interest. scCO2 is a nontoxic, non-flammable substance that is relatively inert and can be used to process
biomaterials at physiologic temperatures and mild pressures. scCO2 treatment avoids
organic solvents, does not leave cytotoxic residue, and has already been utilized in
similar biomedical applications, including sterilization, pasteurization, biomolecule
extraction, and removal of endotoxins, bioburden, and allergenic proteins.
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Supercritical CO2 has been used in foaming of synthetic polymer scaffolds, but it
is almost completely unexplored in treatment of natural biomaterials for TE. In this
dissertation, the potential of scCO2 in natural biomaterial TE is extensively explored.
Two commonly-studied natural TE scaffold biomaterials were examined: a singlecomponent biomaterial, type I collagen, and a multi-component biomaterial, extracellular
matrix (ECM) obtained by decellularization of porcine aorta. Both biomaterials were
studied at the fundamental and applied level.
First, the chemical compatibility of collagen and liquid and scCO2 was assessed.
Compatibility was determined based on changes in four biochemical properties: thermal
stability, molecular weight, secondary structure, and overall appearance. For scCO2, no
significant differences were observed, indicating chemical compatibility. Liquid CO2
treatment caused significant denaturing, though it was hypothesized that the apparent
incompatibility may be a result of treatment conditions rather than total incompatibility.
After chemical compatibility between collagen and scCO2 was established, scCO2
was applied to crosslinked collagen films to extract residual glutaraldehyde after
crosslinking. After 1 hr of scCO2/ethanol treatment, over 95% of residual glutaraldehyde
was removed, reducing the concentration below 1 ppm. Differential scanning
calorimetry analysis showed a high degree of crosslinking and a denaturation temperature
of about 63°C both before and after scCO2 treatment. Tensile testing did reveal a
significant increase in both stiffness and tensile strength caused by scCO2 treatment,
likely resulting from dehydration caused by the ethanol additive. However, this
dehydration is preventable and less disruptive than heat-based removal of residual
glutaraldehyde.

vii

Decellularized ECM is also commonly used as a TE scaffolds. Current
decellularization methods often utilize chemical detergents, which are residually
cytotoxic and can damage ECM composition and ultrastructure. scCO2 has been
proposed as a decellularizing agent, but added ethanol severely dehydrates the matrix.
The second half of this dissertation explores how scCO2 can decellularize a tissue without
dehydrating it. To prevent dehydration, a novel presaturation method was developed
where scCO2 and water are thoroughly mixed before treatment. Presaturation with water
led to mass retention of over 99% in a model hydrogel and over 97% in porcine aorta
during scCO2 treatment, compared to only 46% and 78%, respectively, when dry (pure)
scCO2 was used, proving that dehydration during scCO2 treatment is easily prevented.
Finally, scCO2 was used to decellularize porcine aorta. Contrary to a previous
report, scCO2 alone was unable to achieve complete cell removal, even with a polar
additive. However, when an SDS pretreatment step was used, the same scCO2 treatment
completely decellularized porcine aorta as indicated by histology and DNA quantitation.
Presaturation of scCO2 with water maintained the hydration state of the matrix, better
maintaining the mechanical properties of the native tissue.
This dissertation confirms the potential of supercritical CO2 as a processing
method for naturally-derived biomaterial scaffolds. Further work can be performed to
determine the efficacy of CO2 on different scaffold compositions and morphologies as
well as decellularization of other tissue types. More complex treatments may also be
possible, such as simultaneous sterilization and decellularization. These studies provide
insight into the mechanisms and applications of scCO2 in TE and offer a springboard for
impactful discoveries in the future.
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Chapter 1

Introduction

At the end of 2013, over 120,000 individuals in the United States were registered
on the national organ transplant waiting list. The size of the waiting list has continually
increased over the past 25 years, while the number of donations plateaued in the 2000s
and has slightly declined in the 2010s (see Figure 1.1), with the gap between the waiting
list and the number of annual donations now exceeding 100,000 people [1]. It follows
that the number of deaths for those awaiting transplantation, currently about 8,000 per
year, will continue to increase over time. These statistics clearly indicate that merely
relying on human organ donation will be insufficient for meeting the medical needs of
those requiring organ transplantation, both now and in the future.
One way to address the organ deficit is the production and use of artificial organs.
An artificial organ is a manmade construct that can perform the tasks and functions of a
native organ which has been damaged or excised. Though the concept of artificial organs
has existed for over a century [2], widespread clinical use of artificial organs still does
not exist. One exciting and relatively novel method for creating artificial organs is the
field of tissue engineering (TE). TE involves culturing healthy cells from a patient (or
from a stem cell line if autologous cells are unavailable) to create a new tissue in vitro,
which can then be used as a graft to treat a tissue or organ defect [3]. The TE process is
shown in pictorial form in Figure 1.2.

1

Figure 1.1 – Trends in organ donation in the United States, 1991-2013 (Approved for
reuse by the United States Department of Health & Human Services; URL:
https://optn.transplant.hrsa.gov/the-need-is-real-data/)

2

Figure 1.2 – Tissue Engineering Flowchart – (By HIA (Own work) [CC BY 3.0
(http://creativecommons.org/licenses/by/3.0)], via Wikimedia Commons)
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For example, one can consider how the TE process would be utilized for a patient
with a bone defect. First, a biopsy is taken from the patient’s healthy bone tissue.
Healthy cells are isolated from the biopsy and then cultured in vitro until reaching an
appropriate cell density. Next, the cultured cells are seeded onto a biocompatible threedimensional construct called a TE scaffold along with appropriate growth factors and
mechanical stimuli to create a tissue-engineered graft. Finally, the graft is implanted into
the damaged bone. Once inside the body, the cells continue to proliferate and
differentiate, populating around the scaffold and eventually forming a new tissue or organ
to replace the damaged one. The scaffold is designed to naturally degrade over a set
timeframe and be replaced by newly-deposited extracellular matrix (ECM).
TE works well in theory, but a number of challenges have prevented its success
and widespread clinical use. The biggest challenge is determining the source and design
of the scaffold. An effective scaffold biomaterial must satisfy numerous biological,
chemical, structural, and mechanical criteria, including [4].
-

High biocompatibility/low immunogenicity to prevent host immune response

-

Interconnected pore structure that allows cell penetration

-

Appropriate morphology for the specific tissue or application

-

Suitable elastic modulus (stiffness) and flexural rigidity

-

Structural integrity to withstand pressure and mechanical forces

-

Surface chemistry that is not too hydrophilic or hydrophobic

-

Absence of any residual cytotoxic agents

-

Sterility to prevent infection after implantation

-

Bioactive and able to promote constructive remodeling

4

Two main approaches to creating TE scaffolds are possible: (1) producing scaffolds from
synthetic biomaterials, and (2) using scaffolds derived from natural and/or xenogeneic
sources. Though both approaches have merit, natural biomaterials offer two primary
advantages. First, using naturally-derived scaffolds can reduce the possibility of bodily
rejection and adverse immune response sometimes observed with synthetic biomaterials
[5]. Second, recent research has uncovered the importance of ECM proteins in directing
the tissue towards vascularization, innervation, and proper function; these outcomes are
collectively called “constructive remodeling” [6]. During constructive remodeling, ECM
proteins and their degradation products, including cytokines and chemokines, signal cells
on when to migrate, proliferate, and differentiate [7]. In fact, the constructive remodeling
effect of ECM proteins is so great that for some biomaterial and tissue combinations,
such as collagen for bone tissue and elastin for blood vessels, the primary ECM
component alone can be enough to promote constructive remodeling [8, 9].

1.1

Decellularization
Xenogeneic organs or tissues contain non-autologous (foreign) cells, which must

be removed prior to seeding the matrix to prevent undesired post-implant immune
response [10, 11]. The process of removing foreign cellular material from a tissue or
organ is called decellularization. The objective of any decellularization method is
twofold: (1) to remove all foreign cellular material, and (2) to preserve the physical,
mechanical, and biochemical properties of the ECM [12].
Tissues differ in numerous ways, including variations in cell type, cell density,
physical density, ECM composition, morphology, and thickness. Because of these
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differences, there are numerous, highly-varied decellularization protocols that exist for
different tissues; sometimes there are even very different approaches for decellularizing
the same type of tissue [13]. Decellularization is most commonly accomplished by
contacting xenogeneic tissue with chemical detergents, sometimes in conjunction with
enzymes [14]. Physical methods, such as sonication and agitation, can be used instead of
or in tandem with chemical methods to decellularize a tissue [15]. Common
decellularization methods are discussed in greater detail in Chapter 2.
There is no universal or perfect decellularization protocol. If treatment is too
harsh, the ECM will be damaged, compromising mechanical integrity and bioactive
properties. If the treatment is too gentle, not all foreign cells will be removed,
stimulating unwanted immune response [10]. In fact, it is accepted in the field that no
decellularization treatment will be able to remove all cellular material from a tissue, and
no treatment will be able to completely avoid damaging the ECM [13]. Therefore, the
goal and challenge of creating a decellularization protocol is finding a balance between
preserving enough of the matrix for it to promote constructive remodeling and removing
enough foreign cellular matter to prevent an inflammatory immune response. Both of
these outcomes are required for the recellularized tissue to develop and function properly;
therefore, the efficacy of a given decellularization technique must be determined by
evaluating both criteria. Currently, there are no universally-accepted standards for
determining the extent of decellularization. However, Badylak’s group has recently
proposed standards based on the mass and length of residual DNA fragments and the
absence of cellular material in stained micrographs [12]. There are no universal criteria
at all for successful ECM preservation, but mechanical properties, pore size and structure,
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and ECM protein composition are often evaluated after treatment and compared to the
properties of the native tissue.

1.2

Supercritical Carbon Dioxide
An optimal decellularization technique has not yet been discovered, and

conventional decellularization techniques have several weaknesses that need to be
addressed. Most protocols, especially ones that use chemical detergents, are fairly timeconsuming. Many treatments last on the order of days [16], while treating denser tissues
like blood vessels can take multiple weeks [17], and this time does not include postdecellularization processing steps such as sterilization. Residual detergents can be
cytotoxic [10], as can residual crosslinking agents [18]. Detergents also can have
additional deleterious effects in tissues containing basement membranes, such as bladder
and skin [19, 20]. Because of these issues, novel decellularizing agents and methods for
applying them are still being pursued.
One method of processing biomaterials that has gained interest in recent years is
supercritical fluids (SCFs). A substance enters the one-phase SCF state upon exceeding
both its critical temperature (Tc) and critical pressure (Pc), collectively known as the
critical point (Tc, Pc). Supercritical fluids are effective solvents because they have
desirable transport properties, including minimal surface tension, low viscosity, and high
diffusivity like gases, but they also have liquid-like density and solvation power that are
much greater than those of most gases [21]. This combination of properties allows SCFs
to penetrate through surfaces easily without damaging them because of their lack of
surface tension. Upon depressurization, the supercritical fluid outgases and exits the
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system, avoiding problems with residual cytotoxic components often encountered in
other methods.
Supercritical carbon dioxide (scCO2), shown in Figure 1.3 (b), is especially
promising for biomedical applications. The primary reason is thermodynamic: scCO2 has
unusually low critical conditions. Its Tc of 31.1°C allows treatment of biological
materials at or near physiologic temperature (37°C), and its Pc of 7.4 MPa is mild enough
to treat biomaterials safely. Additionally, CO2 is readily available and safe – it is
relatively inert, non-flammable, non-toxic, and non-mutagenic [21]. Equipment and
processes utilizing supercritical CO2 have already been demonstrated in pasteurization
[22-24], extraction of biological compounds [25, 26], production of TE scaffolds from
synthetic polymers [27-29], and sterilization, the latter being a research thrust in our
group [30-37].
Sterilization is of particular importance in TE to prevent nosocomial (hospitalacquired) infection during surgery. Traditional sterilization methods like steam
autoclaving, ethylene oxide, and gamma irradiation are often unsuitable for biomaterials
[30, 33]. Supercritical CO2 has been proven effective in the sterilization of decellularized
porcine dermis and lung ECM [38, 39] and has been identified as an important subject of
future research in scaffold sterilization [12]. Though not directly investigated in this
dissertation, the possibility of simultaneous decellularization and sterilization or highlevel disinfection using a single CO2 treatment would be a potential boon for the field.
Additionally, scCO2 has recently been used to aid in other TE processes, including for
hydrogel foaming [40] and crosslinking of chitosan aerogels [41]. Furthermore, recent
improvements in scCO2 processing techniques have eliminated the pore interconnectivity
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Figure 1.3 – Visual Appearance of Dense-Phase CO2: Photographs of (a) CO2 in vaporliquid equilibrium and (b) CO2 in the supercritical state.

9

issues that were once a major hindrance to scCO2 polymer foaming techniques [42].
However, despite the efficacy of scCO2 in the aforementioned applications, its use in
treatment of natural TE scaffold biomaterials is very limited. To the best of our
knowledge, there has been no fundamental research on the chemical compatibility of
scCO2 with natural biomaterials, such as collagen, and applied work in the literature is
very limited. Decellularization with scCO2 is completely unexplored aside from a single
publication by Sawada’s group in 2008, where significant matrix dehydration was
reported and no further reports were published [43].

1.3

Dissertation Objectives
The overarching objective of this dissertation is to evaluate the potential of scCO2

for use in the processing and fabrication of naturally-derived TE scaffolds. This
objective was accomplished by using scCO2 to treat a simple natural biomaterial, type I
collagen, and a more complex natural biomaterial, porcine aorta tissue. As shown in
Figure 1.4, a fundamental study and an applied study were performed for each
biomaterial. The specific aims of this work are: (1) to determine the fundamental
compatibility of type I collagen with liquid and supercritical CO2, (2) to extract residual
glutaraldehyde from crosslinked type I collagen films using scCO2, reducing
glutaraldehyde concentration below cytotoxic levels, (3) to design and develop a method
for presaturating scCO2 with water and other volatiles to prevent dehydration of model
scaffold biomaterials, and (4) to decellularize porcine aorta tissue using a scCO2-based
treatment process and determine the relative effects of key process parameters on cell
removal and scaffold properties.

10

Figure 1.4 – Dissertation Flowchart: Supercritical CO2 was used to treat both type I
collagen and porcine aorta in fundamental and applied studies.

11

Very little work has been done previously on fabrication of TE scaffolds with
scCO2. The findings of this dissertation will elucidate fundamentals of how supercritical
fluids and scaffold biomaterials interact. This knowledge can be leveraged into
numerous applications for future clinical and industrial benefit in TE and the fields of
chemical and biomedical engineering.
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Chapter 2

Literature Review

In recent decades, industrial and research interest in supercritical CO2 technology
has seen a considerable increase in a wide variety of applications, including many in the
biomedical field [44-46]. In recent years, TE has also seen continual growth and progress
in research and development [3, 13, 47]. As this dissertation lies at the intersection of
these two important and expanding areas, this chapter includes discussion of current
knowledge and critical publications in both scCO2 and TE. The objective of this chapter
is to establish where and how this dissertation fits into both fields.

2.1

Supercritical CO2 Technology
Prior to covering the most prominent applications of scCO2, some background on

its unique thermodynamic and chemical properties will be discussed. This subsection
will then cover extraction, the primary industrial application of scCO2, with a focus on
extraction of biological compounds. It will conclude with discussion of two areas of
scCO2 technology highly relevant to this dissertation: sterilization and TE applications.

2.1.1 Supercritical CO2 Fundamentals
A pressure-temperature phase diagram for a pure substance, such as that of CO2
shown in Figure 2.1, consists primarily of planar one-phase regions (solid, liquid, and
vapor) and two-phase curves where thermodynamic equilibrium exists between the two
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phases. These curves on Figure 2.1 are A, the solid-vapor (sublimation) curve; B, the
solid-liquid (fusion) curve; and C, the liquid-vapor (vaporization) curve. There also two
pressure-temperature coordinate points of interest. Point D is the triple point, where the
solid, liquid, and vapor phases exist in three-phase equilibrium. More importantly for
this work, point E is the critical point. As the critical point is approached, the liquid and
vapor phases approach equal densities and the phase boundary disappears. Once the
pressure and temperature of the critical point are exceeded, the substance enters the
supercritical fluid phase [48].
Supercritical fluids have a unique combination of properties: densities on the
order of liquids but diffusivities and viscosities on the order of gases. Along with having
minimal surface tension, these solvent properties allow SCFs to penetrate into pores,
films, and surface openings without damaging them. SCFs are green, sustainable
replacements for organic solvents in many applications, especially in the area of cleaning
materials and surfaces [49]. CO2 is one of the most commonly used supercritical fluids.
It is non-toxic, non-flammable, non-mutagenic, relatively inert, odorless, readily
available, and fairly inexpensive [21]. It also has relatively low critical conditions (Tc =
31.1C, Pc = 7.4 MPa), making it particularly well-suited for biological applications. A
myriad of molecules have some degree of solubility in scCO2, especially small, non-polar
ones [50]. Solubility of polar compounds is sometimes limited, but can be improved in
many cases by dissolving a polar additive, such as ethanol, in scCO2, [51].
CO2 in the liquid phase is also of interest. Liquid CO2 exists at similar,
sometimes greater densities than scCO2, and is therefore also considered a “dense-phase”
fluid. Liquid CO2 can exist at pressures as low as 1 MPa, making it desirable for
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Figure 2.1 – Carbon Dioxide Phase Diagram: A – Sublimation Curve; B – Fusion Curve;
C – Vaporization Curve; D – Triple Point; E – Critical Point; F – Critical Point Drying
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applications where the higher temperatures and pressures of supercritical CO2 are
detrimental, either physically to the specimen or economically because of the higher
equipment cost [52, 53].
One important application of liquid CO2 is critical point drying (CPD), a process
commonly used in TE [54] and other applications, such as electronics processing [55],
aerogel formation [56], and scanning electron microscopy [57]. The primary advantage
of CPD over conventional evaporative drying is that CPD avoids passing through the
vaporization curve of the phase diagram; circumventing the two-phase region is desirable
for delicate materials that can be damaged by the surface tension that exists at vaporliquid phase boundaries [58]. As shown on line F in Figure 2.1, CPD initiates when a
liquid solvent, such as ethanol, is removed from a substrate by dissolving it in a second
benign solvent, typically liquid CO2. The mixture is then heated and/or pressurized until
CO2 undergoes a phase transition from the liquid state to the supercritical state. Finally,
the pressure is reduced below the critical pressure, allowing the supercritical CO2 to enter
the gaseous state without undergoing the vapor-liquid phase transition. The gaseous CO2
is removed from the system by depressurizing to ambient conditions.
Dense-phase CO2 has been utilized in a wide variety of applications, including
reaction engineering [59], catalysis [60], polymerization [61], chromatography [62],
particle synthesis [63], thin film synthesis [64], jet cutting [65], textile dyeing [66], and as
a heat transfer fluid [67]. However, this section will focus on the three realms of CO2
technology most relevant to this dissertation, which include extraction, sterilization, and
tissue engineering.

16

2.1.2 Extraction
Extraction, the process of separating one component from another using a solvent,
is one of the most widespread applications of supercritical CO2 [21]. One of the oldest
and best-known SCF extraction process is the decaffeination of coffee [68], which has
more recently been extended to tea and spent coffee grounds [69, 70]. CO2-based
extraction has some inorganic applications, such as removal of metal ions from water and
other materials [71, 72], but the main focus of supercritical extraction is on biological
molecules. The extraction of oils, lipids, and organic solvents are of particular interest to
TE applications.
Supercritical CO2 extraction of animal and plant oils for supplemental and
medicinal use has gained considerable attention in recent years. For example, Ferdosh et
al. used scCO2 and an ethanol additive to extract and fractionate fish oil, which contains
healthy omega-3 fatty acids. The fish oil was extracted from undesired and/or inedible
tuna parts in a 2 hr process, though 3 days of pretreatment freeze-drying were required
[73]. CO2 extraction of plant oils has been studied extensively, as well. Plant oils
containing fatty acids, one of the two subgroups of lipids, have been traditionally
extracted using either a mechanical press or organic solvents, such as hexane or
petroleum ether [74]. However, scCO2 has gained popularity in this field because it
offers higher yields than a mechanical press without the environmental and safety hazards
of organic solvents [75]. Some materials are extracted from plant by-products, such as
lycopene from tomato peels [76], but most oils are extracted from seeds. Some types of
plant oils successfully extracted with supercritical CO2 include tea seed [75], sunflower
seed [77], and sesame seed [78], among many others.
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A key subset of fatty acid-containing oils is those containing conjugated linolenic
acids, which may help prevent atherosclerosis and fight some types of cancer [79]. Özkal
et al. extracted flaxseed oil, an abundant source of α-linolenic acid, in 30-60 minutes of
scCO2 treatment with yields of about 0.3 g/seed [80]. scCO2 extraction of G.
Pentaphyllum (a Chinese herb) seeds for 160 min yielded an oil containing over 88%
conjugated linolenic acids, which inhibited the viability of both leukemic and colon
cancer cells by about 80% [81]. Another notable subset of fatty acids is phytosterols,
which may lower cholesterol and the risk of heart disease [82]. Phytosterols have been
extracted from many seed oils using scCO2, as well as other natural sources, such as bee
pollen [83].
Along with fatty acids, the other subgroup of lipids is glycerides, which include
waxes, triglycerides, and phospholipids [74]. Phospholipids are of particular interest for
scCO2-based decellularization, as they are a primary component of cell membranes.
However, phospholipids have been studied in much less detail than fatty acids, likely
because their high polarity makes them more difficult to extract. Still, some progress has
been made in this area. Tanaka et al. were able to extract phospholipids from salmon roe
with up to 80% purity, though high concentrations of added ethanol were needed [84].
Phosphatidylcholine has been extracted from inedible egg parts with scCO2, but a twostep process was required and yield still was relatively low (< 50 g/kg) [85]. More
recently, phospholipids were extracted from activated sludge using scCO2 to assess soil
quality [86]. However, more work is needed to determine if extraction of cell membrane
components is a viable approach to decellularization.
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2.1.3 Sterilization
TE scaffolds must be sterilized before implantation, as hospital patients have an
elevated risk of nosocomial infection because of weakened immune systems, close
quarters, and the necessity of invasive procedures and implements [87]. This risk is
especially high in intensive care units [88]. Thus, sterilization of all medical devices and
implants is critical for patient safety. Numerous methods exist to sterilize materials, but
most have one or more significant drawbacks for a biomedical application. The high
temperature and humidity of steam autoclaving can denature proteins and damage fibrous
and polymeric materials [89]. Ethylene oxide is toxic, flammable, and possibly
carcinogenic [90]. Gamma irradiation has been shown to cause unwanted changes in the
molecular weight, glass transition temperature, and water content of TE biomaterials
[91]. Liquid sterilants such as phenols, glutaraldehyde, and peracetic acid are eye and
skin irritants with varying degrees of toxicity [92].
Dense-phase CO2 is often used for sterilization of biomaterials because it does not
present any of these drawbacks. Spilimbergo’s group has done extensive work on the
mechanisms of cell deactivation by scCO2. Through in situ fluorescence staining, they
have shown that cell death primarily occurs from CO2 permeation of the lipid bilayer in
the cell membrane [93]. CO2 enters the cell, lowering cellular pH and deactivating
enzymes [94, 95]. Bacterial spores are typically more difficult to kill than vegetative
bacteria. Our group showed using transmission electron microscopy that scCO2 damages
the spore envelope, but a lethal oxidizing additive, such as hydrogen peroxide, must then
be absorbed by the cell to complete the deactivation process [35]. Pressure cycling
and/or electric pulses also improve spore deactivation [44].
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The parameters required to achieve sterilization are or at least high-level
disinfection (which does not require removal of spores) are somewhat applicationdependent, but usually the supercritical CO2 phase is used. A temperature of 40°C or
above and a pressure of 20 MPa or higher (or a more moderate 8-15 MPa range with
pressure cycling) are usually adequate [44]. Deactivation of vegetative bacteria and
bacterial spores from biomaterials using scCO2 has been demonstrated numerous times
by our group and many others [34, 96, 97], and is also commonly done in pasteurization
and food processing [22, 98]. However, comparatively little work has been done on virus
deactivation with scCO2. In the late 1990s, Larzul’s group used scCO2 to remove viruses
from bone allografts, though three additional processing steps were required after scCO2
treatment to achieve high levels of virus deactivation [99]. Recently, nitrous oxide (N2O)
and fluorocarbons have been proven more effective for virus removal under most
circumstances, possibly because N2O is pH neutral instead of acidic [44]. N2O has
similar critical conditions like CO2, but is often avoided because of safety concerns; it is
strong oxidizer that can cause explosions in the presence of an organic fuel source [100].
The microbial removal properties of supercritical CO2 also extend beyond viruses
and bacteria. Exploratory research has shown potential for supercritical CO2 in pest
control during food storage [101]. In our lab, the solubility of tea tree, hinoki, and cedar
wood oils in supercritical CO2 has been utilized to create an acaricidal treatment on
household objects for the prevention of asthma [102]. These technologies still have
ample room for exploration and development.
Though supercritical is usually the preferred CO2 phase, liquid CO2 has been used
in some sterilization applications. There are three situations that make liquid CO2
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particularly desirable for an application: (1) when cost of equipment is a limiting factor,
(2) when the higher pressures and temperatures required by the supercritical phase would
be deleterious, or (3) when surfactant additives are used, since their solubility in CO2 is
often inversely proportional with temperature [53, 103]. In our group, Jimenez et al.
were able to use liquid CO2 to completely sterilize a model hydrogel [32], and Tarafa et
al. successfully removed bacterial endotoxin from titanium disks using water, liquid CO2,
and commercial surfactant Dehypon Ls-54 [104, 105]. Liquid CO2 has also been used to
sterilize textiles [52].
For the purposes of this dissertation, it is worth noting that there are two
publications where scCO2 was used to sterilize an acellular material. In 2009, Qiu et al.
used scCO2 to sterilize acellular porcine dermis [38]. Small pieces of ECM were
sterilized using supercritical CO2 with a peracetic acid additive. In under 30 minutes, 6
log reduction was attained for Bacillus atrophaeus, a bacterial spore that has traditionally
been analyzed for sterilization effectiveness [31, 35]. They also studied removal of
encephalomyocarditis (EMC) and other viruses, and attained complete virus removal in
15 minutes of scCO2 treatment, which was more effective than two hours of treatment in
peracetic acid alone. Additionally, scCO2 treatment caused less than a 2% change in
matrix weight, showing a relatively mild impact of treatment. Balestrini et al. similarly
utilized scCO2 to sterilize acellular lung ECM while maintaining key scaffold properties
[39]. Supercritical CO2 appears to have considerable potential for ECM sterilization, but
more research is needed, particularly on larger or three-dimensional samples. This
research may soon occur given the recent classification of xenogeneic scaffolds as
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medical devices by the United States Food and Drug Administration (FDA), thereby
requiring terminal sterilization prior to clinical use [106].

2.1.4 Synthetic TE Scaffolds
CO2 has long been known to create pores in polymeric substances during
depressurization, even in the gaseous phase. This process is often called polymer
foaming, and it occurs because CO2 plasticizes the polymer, liquefying it and increasing
its density. Upon depressurization, CO2 nucleates and forms gas bubbles when leaving
the polymer, creating a pore network [107]. Two main criteria are necessary for a
polymer to undergo this process: (1) moderate to high affinity for CO2 and (2) a glass
transition temperature below the processing temperature [108].
Careful manipulation of process variables, such as pressure, treatment time, and
depressurization rate, can lead to predictable porosity and average pore size of the treated
biomaterial. A groundbreaking paper demonstrating this was published by Howdle’s
group in 2007 [29]. They studied scCO2 foaming of poly(lactic acid), PLA, and
poly(lactic-co-glycolic acid), PLGA, in considerable depth. Their work included a
factorial design of temperature, pressure, molecular weight, glycolic acid concentration,
depressurization rate, and treatment time. They found increasing temperature and
depressurization rate to be directly proportional to pore size, while increasing pressure,
treatment time, molecular weight, and glycolic acid concentration were indirectly
proportional to pore size. Porosity was in the acceptably high 70-80% range in most
cases, except for very high glycolic acid concentrations, where it decreased considerably.
A more uniform pore size distribution was found for scCO2 compared to gaseous CO2,
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likely because the higher diffusivity in the supercritical state creates a more uniform
distribution of CO2 within the plasticized polymer.
Recently, the use of inert particulate additives and CO2/water/surfactant
emulsions has considerably improved pore interconnectivity, overcoming a significant
barrier to the viability of scaffolds fabricated using this technique [42]. CO2 has also
been used to augment other scaffold fabrication methods, including emulsion templating
[109], microsphere sintering [110], phase inversion [111], electrospinning [112], and
biomolecule impregnation [113].
Another concern during any scaffold treatment is loss of bioactivity caused by
chemical reactions that alter surface chemistry. Loss of bioactivity could inhibit cellular
function or cell adhesion to a scaffold. However, scCO2 is relatively inert and has been
shown to not adversely affect bioactivity of both synthetic bone scaffolds and essential
oil extracts [114, 115]. Still, establishing bioactivity of a natural scaffold after scCO2
treatment would be an important step.
Since CO2 also can be used to sterilize TE scaffolds, the amount of processing
steps can potentially be reduced by using CO2 to both form and sterilize the scaffold [33].
Like with extraction and sterilization, the supercritical phase is much more commonly
used in scaffold treatment, but liquid CO2 has been shown to have compatibility with
some synthetic polymers, particularly ones with higher crystallinity [116]. CO2 sorption
is so high in amorphous materials that it often causes irreversible effects from extreme
amounts of swelling; the compatibility of CO2 crystalline materials is likely caused by
their reduced free volume compared to amorphous materials [117].
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Very little work has been done on CO2 and natural polymers, including potential
TE scaffold biomaterials. Though supercritical CO2 has been applied sparingly to leather
processing in the past decade [118, 119], to our knowledge no work has been done prior
to this dissertation on the fundamental interactions of collagen and dense-phase CO2.
However, Reverchon’s group recently created chitosan aerogels by lyophilization,
crosslinked them with glutaraldehyde, and then removed almost all glutaraldehyde (final
concentration below 0.1 ppm) using scCO2 and ethanol [41, 120]. This clearly presents
an opportunity for scCO2 in crosslinking of naturally-derived scaffold materials. Recent
reviews in the decellularization field have also recognized the potential for sterilization
ECM with scCO2 and recommend further research in the area [12, 13], but aside from the
aforementioned sterilization work [38, 39], no literature is available on the subject.
There is one publication where scCO2 is used in decellularization. Sawada et al.
used scCO2 and an ethanol additive to decellularize porcine aortas [43]. They reported
100% removal of DNA and 80-90% removal of phospholipids at relatively mild pressures
and temperatures. However, problems with tissue dehydration, inability to completely
rehydrate, loss of mechanical strength, and residual phospholipids were reported.
Though this paper was published in 2008, to our knowledge no follow-up or similar
studies have been published since. Chapter 6 of this dissertation includes our efforts to
replicate and improve upon Sawada’s findings.

2.2

Natural Biomaterial TE Scaffolds
We now turn our attention to the broad topic of TE scaffold design and

fabrication. Two main routes exist for the fabrication of TE scaffolds: (1) synthetic
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biomaterials, including synthetic polymers and composites, and (2) natural biomaterials.
While the former path has scientific merit and does offer some advantages, it is beyond
the scope of this dissertation and will not be discussed in greater detail. For further
reading on the subject of artificial TE matrices, the reader is encouraged to examine the
thorough review by Cho’s group [47].
There are two primary avenues for production of TE scaffolds composed of
natural biomaterials. The first is scaffolds composed primarily of one major ECM
protein, often collagen, which are formed into a desired shape and size by various
methods (e.g. electrospinning, lyophilization, etc.) [121]. The other subgroup is scaffolds
composed of ECM; these are created by decellularization of an animal tissue, with the
resulting ECM being used as the scaffold [122]. A great amount of variation exists in the
methods by which natural biomaterial TE scaffolds are produced. Some of the most
common and most pertinent to this work are explored in this subsection.

2.2.1 Collagen Scaffolds
The extracellular matrix gives structural support to cells, spatial cues for tissue
growth, and direction for cell behaviors and functions [123]. These features all make
collagen a desirable scaffold material. Collagen is the most abundant protein in the ECM
of most tissues; it therefore has numerous sources in the body and is an intuitive
candidate for a natural biomaterial scaffold, especially if decellularization of the whole
ECM is challenging [124]. Though having the entire ECM is ideal for promotion of
constructive tissue remodeling [7, 125], collagen has been shown to regulate cell
adhesion, migration, proliferation, and differentiation and is often easier to isolate [126].
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The advantages of collagen as a scaffold substrate are numerous. In addition to
its role in remodeling, collagen has low immunogenicity and antigenicity, is porous and
permeable, and has controllable biodegradability based on its extent of crosslinking. It
also biodegrades in a more favorable way than many synthetic materials. While synthetic
materials degrade from an immune response mediated by macrophages, ECM proteins
like collagen elicit a less aggressive immune response that is mediated by matrix
metalloproteinases and growth factors, stimulating natural tissue growth during scaffold
degradation [4].
There are also numerous sources of collagen available. Human collagen can be
harvested from the placenta [127], but most collagen traditionally comes from
mammalian sources, including cow, pig, rat, and sheep. More recently, fish collagen has
also been purified from parts that are normally discarded [128]. Finally, studies have
been done to produce recombinant collagen; this could be important if collagen scaffolds
experience a significant rise in usage, as yields from animal sources are often low [129].
Some scaffolds are made from pure collagen, usually a combination of types I, II,
and III, since these are most common in the human body. One common fabrication
method is lyophilization, or freeze-drying. Lyophilization protocols involve placing a
collagen gel or solution into a specific shape or mold, then freezing it and removing the
water. Scaffold properties can be manipulated by changing collagen concentration and
freezing time [130]. Another popular approach is electrospinning. In this method,
collagen is placed in a syringe or spinneret, charged with high voltage, and a jet
eventually shoots at a grounded target once the potential difference is high enough,
evaporating the solvent and creating a fiber [131]. These fibers can be manipulated into
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various shapes and sizes. Finally, extrusion methods utilize syringe pumps to flow
collagen solutions into a desired shape or area. Collagen can be extruded into different
geometries based on the design of the extruder, such as the Yost group’s tubular design,
which has been used to make TE scaffolds for heart, bone, and blood vessel tissues [4,
132-134].
The main disadvantage of collagen as a scaffold material is that it lacks
mechanical strength, especially when fully hydrated [121]. Collagen is often physically
or chemically crosslinked to improve its mechanical strength. Common physical
crosslinking methods include dehydrothermal treatment and ultraviolet or gamma
irradiation [135]. Chemical crosslinking has been traditionally done with glutaraldehyde
or azides [136], but these chemicals are cytotoxic if not fully removed [18, 137]. Less
hazardous crosslinkers have been pursued recently, including EDC [138], genipin [139],
and riboflavin [140], but these alternatives may be less potent [141].
Instead of crosslinking, the mechanical strength of collagen can be strengthened
by incorporating an additional material into the scaffold to create a collagen blend. These
materials include polymers, composites, and ceramics. Some polymers, like poly(εcaprolactone) (PCL), are synthetic polymers used commonly in TE and add mechanical
strength and control over degradation rate [142]. Natural polymers are used as well; for
example, silk fibroin adds mechanical strength to collagen and also provides extra
adhesion sites during cell seeding. For example, Wei et al. used a collagen/PCL/silk
fibroin blend to create a bladder scaffold that promoted proliferation of epithelial cells
[143]. Other common blending materials include hydroxyapatite, a ceramic often used in
bone tissue scaffolds for its osteoinductivity [144], and carbon nanotubes, which can
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increase scaffold stiffness and promote cell differentiation [145]. Growth factors can also
be incorporated into collagen scaffolds, particularly during electrospinning [146].

2.2.2 Decellularized ECM Scaffolds
Decellularized scaffolds are fabricated by removing DNA and cellular matter
from an animal tissue and using the recovered ECM as a TE scaffold. The primary
benefits of ECM scaffolds are low immunogenicity and the capacity for constructive
remodeling after recellularization [5-7, 125]. Constructive remodeling involves the
development of nerves, vasculature, and proper tissue function after a scaffold is
implanted. It occurs as a result of an anti-inflammatory immune response mediated by
Th2 helper cells and M2 macrophages, rather than the pro-inflammatory Th1 cells and
M1 macrophages normally observed in the deposition of scar tissue [106]. This type of
response is associated with ECM scaffolds specifically [147, 148].
Decellularization has been performed on almost every tissue in the body,
including adipose [149], bladder [150], blood vessel [151], bone [152], brain [153],
cornea [154], esophagus [155], heart [156], intestine [157], kidney [158], liver [159],
lung [160], nerve [161], skin [162], trachea [163], and others. Decellularized tissues
originate from several different mammalian sources, most commonly porcine, bovine,
ovine, or murine, among others [13]. There are numerous decellularization methods and
agents, but decellularization techniques are usually categorized as physical, chemical,
enzymatic, or a combination of the three [12].
Chemical treatment often involves removal of cells with chemical detergents
(surfactants). The two most common detergents are sodium dodecyl sulfate (SDS) and
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Triton X-100; they are nearly ubiquitous in the field. SDS is an ionic detergent and
functions by solubilizing DNA and lipid membranes, as well as disrupting covalent
protein-protein bonds. The main drawbacks of SDS are residual cytotoxicity and
disruption of glycosaminoglycans (GAGs) and other ECM molecules [122, 164]. Triton
X-100 is a non-ionic detergent that solubilizes proteins; it is less disruptive to ECM, but
fails to decellularize denser tissues [165]. Zwitterionic detergents, such as tributyl
phosphate [166] and CHAPS [160], maintain the native charge and state of proteins and
are often effective in decellularizing thin tissues. Any detergent will eventually cause
ECM degradation, so they are usually limited to very low concentrations and/or short
treatment times [167]. Chemical treatment can also include acids, bases, or organic
solvents, though these can significantly alter ECM mechanical properties and chemical
composition and are less common [155, 168]. Of particular note for this study is
Lumpkins’ use of ethanol in decellularization. As in Sawada’s work, considerable
dehydration was reported, with ECM stiffness increasing threefold [168].
Biological agents can destroy and remove cellular material from tissues. In
particular, certain enzymes can break the bonds in large organic molecules, such as
peptides and nucleotides. For example, in adipose decellularization, Choi et al. used
DNase and RNase in conjunction with SDS to achieve more complete decellularization
than SDS alone [149]. Chelating agents, such as EDTA, can aid cell removal by
increasing membrane permeability and by breaking adhesions between cells and the
ECM via disruption of calcium transfer [169].
Finally, physical treatment can be used to detach cells from the ECM. Agitation
and sonication are used to burst cells or dislodge them from the ECM [15, 170]. High
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hydrostatic pressure (HHP) followed by extended washing has been used to decellularize
aortic tissue [171], suggesting potential for scCO2 in decellularization, as its pressure is
far lower than HHP. Another common physical treatment is electroporation, where cell
membranes are lysed by electrical pulses [172, 173]. These and other physical
decellularization methods, such as temperature treatment and pressure gradients, are
described in greater detail by Keane et al. [13].
Of particular note for this dissertation is the decellularization of blood vessels by
Simionescu’s group [151, 174, 175]. In particular, they have had considerable success
with immersion decellularization of aorta and aortic roots using a 16-day treatment of
SDS, Triton X-100, sodium deoxycholate, and EDTA followed by 4 days of enzymatic
treatment. The resulting ECM was acellular and responded well to biaxial mechanical
testing [17]. The group also created elastin scaffolds for arterial TE in diabetic patients
by decellularizing in sodium hydroxide, which removed most of the collagen [9].
Though these scaffolds are of excellent quality, they are time-consuming to produce. If
successful, scCO2 decellularization would offer a significant reduction in treatment time.
The term “decellularization” once referred primarily to the treatment of tissues,
small layers of cells that compose part of an organ. Now, much research is being done on
whole-organ decellularization. This potentially represents a great improvement in
fabrication efficiency because macroscopically large volumes can be decellularized using
just one treatment process, with the ultimate objective being the ability to engineer and
mass-produce entire organs for patients in need of organ transplants [176]. Most wholeorgan decellularization processes use a technique called perfusion to apply the
decellularizing agent. A perfusion system involves connecting a small tube to the native
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vasculature (e.g. Baptista et al. chose the portal vein in whole liver decellularization
[159]) and then applying a small flow (usually on the order of 1 mL/min) of one or more
decellularizing agents throughout the organ’s vasculature for several hours or days [177].
This can uniformly decellularize a three-dimensional structure. Recellularization has
proven extremely challenging, but is usually attempted using a perfusion bioreactor with
cell media.
Because of the many different treatment types and the lack of universal standards
for both decellularization and ECM properties, it is difficult to compare different
decellularization protocols and results. The characteristics of a successfully
decellularized tissue or organ are generally agreed upon in the field – the material should
be (1) acellular, (2) sterile, and of the same (3) mechanical strength (4) biochemical
composition and bioactivity as before treatment. Yet, there is little-to-no agreement on
quantitative standards to determine if these criteria have been met, and the ability to
confirm decellularization is critical given the severe inflammation and rejection caused
by implantation of an incompletely decellularized construct [10].
Crapo et al. addressed this lack of a universal standard in their 2011
decellularization review [12], and suggested the following characteristics to define a fully
decellularized material:
1. Less than 50 ng of double-stranded DNA per mg ECM (dry weight)
2. DNA fragment length of less than 200 base pairs
3. No “visible nuclear material” after DAPI and/or H&E staining
However, this has yet to become a widespread standard, and in their words the standard
“may be too stringent, sufficient, or too liberal.” Furthermore, this decellularization
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standard only addresses the first of the four points mentioned above. Desired sterility of
implanted medical devices, including xenogeneic scaffolds, has been established by the
FDA at 6 log reduction of pathogens [37]. However, quantitative standards on the
mechanical and biochemical properties of decellularized scaffolds are still needed.
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Chapter 3
3.1

Fundamental Interactions of Type I Collagen and Dense-Phase CO2

Introduction
Collagen is the most abundant protein in the human body and has been studied at

length as a biomaterial for TE scaffolds [121]. Some common methods for fabricating
collagen scaffolds include electrospinning [146], lyophilization [130], extrusion [8], and
gelation [178]. The advantages of collagen scaffolds are numerous. Collagen is a key
player in tissue growth and remodeling, having been shown to direct cell adhesion,
migration, and proliferation [126]. Collagen has low immunogenicity and antigenicity, is
porous and permeable, and its biodegradation rate can be controlled by the extent of
crosslinking [123]. It also elicits an anti-inflammatory immune response rather than the
pro-inflammatory response of many synthetics [4]. There are numerous sources of
collagen available, including mammalian [179], fish [128], and recombinant [129].
The main disadvantage of collagen as a scaffold material is that it lacks adequate
mechanical strength, especially when hydrated [121]. For this reason, collagen is often
treated improve its mechanical strength; in fact, collagen has been treated ever since the
first production of leather many decades ago [180]. One approach is material blending,
the addition of a second biomaterial to improve mechanical strength. The primary
advantage of material blending is that it allows the engineer to tailor the properties of the
scaffold based on the properties of the material chosen. Materials commonly added
include natural polymers like silk fibroin [181], synthetic polymers like
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poly(ε-caprolactone) [142], carbon fibers or nanotubes [182], and ceramics such as
hydroxyapatite [144].
Collagen is also commonly processed using solvents. One reason for such
treatment is crosslinking, which improves the mechanical strength of collagen without the
need of material blending. Physical crosslinking is accomplished by ultraviolet
irradiation or dehydrothermal treatment [135]. Also quite common is chemical
crosslinking, often done with glutaraldehyde [136]. However, glutaraldehyde is
cytotoxic if not fully removed [18], and the removal process is often difficult. Less
hazardous crosslinkers have also been pursued recently, including carbodiimides [138],
genipin [139], and riboflavin [140]. Collagen is treated with alcohols and phenols in
other applications, but these compounds can affect the thermal and conformational
stability of the collagen triple helix [183].
Given the extensive amount of collagen processing that occurs, novel solvents
could significantly benefit the field. One solvent that we feel has been overlooked is
supercritical CO2. Below its critical temperature and pressure, a pure fluid can exist in
two-phase vapor-liquid equilibrium. But upon exceeding the critical values, a pure fluid
exists as a one-phase supercritical fluid. Supercritical fluids have low diffusivities and
viscosities like gases, but high densities like liquids; these properties make them desirable
solvents [21]. Supercritical CO2 is of particular interest because of its unusually low
critical temperature of 31.1°C, allowing treatment of biomaterials at physiologic
temperature (37°C). CO2 is also non-toxic, non-flammable, chemically inert, and readily
available. Supercritical CO2 has already been utilized in a number of other biomedical
applications, including extraction of biomolecules [25, 73, 80], polymer foaming [28,
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29], decellularization [43], and sterilization, a focus area for our group [30-37, 104, 116].
Additionally, Reverchon’s group recently used scCO2 to extract residual glutaraldehyde
from a crosslinked chitosan aerogel [41]; the same is almost certainly possible for
collagen scaffolds.
Very few published reports of scCO2 treatment of collagen exist, and they are
very development-oriented, such as sterilization of collagen sponges [184] and infusion
of transglutaminase into leather [185]. To our knowledge, no one has studied the
fundamental interactions between collagen and scCO2 or assessed their chemical
compatibility. Chemical compatibility exists if two molecules do not react when one is
exposed to the other, and if exposure does not cause thermal phase changes in one or both
species (in the specific case of proteins, the phase change is denaturation) [186, 187].
Additionally, there has been no published study on treatment of collagen with liquid CO2.
CO2 in the liquid phase can be desirable for applications constrained by equipment cost
or the higher temperatures or pressures needed for scCO2. [32, 33, 104]. Liquid CO2 is
known to be compatible with crystalline synthetic polymers [116], making collagen a
likely candidate for liquid CO2 compatibility given its high crystallinity.
The objective of this study is to observe how the native collagen triple helical
structure responds to treatment with liquid and supercritical CO2. This will be done by
analysis of three properties before and after CO2 treatment: (1) thermal stability, (2)
molecular weight distribution, and (3) changes in secondary structure. After establishing
how dense-phase CO2 and collagen interact, viable applications for CO2 processing of
collagen will be elucidated.
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3.2

Materials and Methods
The experiments performed were chosen to determine how liquid and

supercritical CO2 affect the physical and biochemical properties of type I collagen.

3.2.1 Collagen Fiber Extrusion
A 1% (w/v) type I bovine corium collagen dispersion in water was obtained from
the Yost group (Medical University of South Carolina, Charleston, SC), prepared in their
lab as described previously [4]. The collagen was extruded into fibers based on the
method of Dunn’s group [181]. An aliquot of collagen was thawed overnight at 4ºC and
the pH was reduced to 2.4 using 1 M hydrochloric acid. The collagen was vortexed once
every 10 min for 30 min (3 times total) and then centrifuged at 5000 rpm for 15 min to
degas. During vortexing and centrifugation, a fiber formation buffer (FFB) was prepared.
This buffer consisted of 0.135 M NaCl, 0.03 M N-[Tris(hydroxymethyl)methyl]-2aminoethanesulfonic acid (TES), and 0.03 M sodium phosphate dibasic heptahydrate
(SPDH). The buffer was heated to 37ºC and sodium hydroxide pellets were added to
increase the pH to 7.5.
After collagen centrifugation, the FFB was poured into a Pyrex container with
large surface area and the collagen dispersion was loaded into a syringe pump attached to
1.59 mm (1/16 inch) diameter polyethylene tubing. The collagen was then extruded
through the tubing and into the FFB at a 0.1 mL/min flow rate. The self-assembled
fibers, usually 10-15 cm in length and 1.5 mm in diameter, rose to the surface from
buoyancy forces. After 10 minutes, the FFB was siphoned and replaced with isopropanol
and the fibers were soaked for 4 hr to remove residual buffer. Finally, fibers were
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removed from the isopropanol and dried overnight under the tension of their own weight.
Dried collagen fibers were stored at room temperature until CO2 treatment.

3.2.2 Dense-Phase CO2 Treatment
Collagen fibers were placed in a 25 mL cylindrical stainless steel pressure vessel
with threaded endcaps (Waters Corp., Milford, MA) and secured in an upright position
using small rare earth magnets prior to treatment with CO2. Fibers were treated with
dense-phase CO2 in one of two states: the liquid phase, 8 MPa and 10°C (ρCO2 = 0.903
g/mL), or the supercritical phase, 20 MPa and 37°C (ρCO2 = 0.856 g/mL), under dynamic
conditions (1 mL CO2/min).
A schematic of the apparatus used can be viewed in Figure 3.1. Bone-dry grade
carbon dioxide (1) (99.8% purity with siphon tube, Airgas National Welders, Charlotte,
NC) was compressed in a chilled syringe pump (3) (500 HP Series, ISCO Inc., Lincoln,
NE) and slowly injected into the pressure vessel (4), which was maintained at the desired
temperature by the environmental chamber (5) (ESPEC Corp. LU-113, Osaka, Japan).
The pressure in the vessel was maintained by a back-pressure regulator (6) (TESCOM,
Elk River, MN). After 1 hr of exposure to CO2, the system was depressurized at a
controlled rate of 0.34 MPa/min (50 psi/min) using a manual hand pump (7) (High
Pressure Co., Erie, PA). Valves and fittings rated for pressures up to 68.9 MPa (2) (High
Pressure Co., Erie, PA) were used throughout the system.
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Figure 3.1 – Collagen Fiber Testing Schematic: 1 – CO2 Supply; 2 – High Pressure
Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation Chamber; 6 –
Collagen Fiber; 7 – Manual Hand Pump; 8 – Pressure Gauge; 9 – Back-Pressure
Regulator
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3.2.3 Bicinchonic Acid Assay
Protein concentrations of solutions used in the following sections were
determined using the bicinchonic acid (BCA) assay. To perform the BCA assay, 25 μL
of a solution of unknown protein concentration was loaded into one or more wells in a
96-well plate and mixed with 200 mL of the BCA working reagent (Thermo Scientific,
Waltham, MA). The unknown samples and a set of known bovine serum albumin (BSA)
standards were scanned at 562 nm with microplate reader. Optical density readings of
the BSA standards were used to create a standard curve, which was subsequently used to
determine the concentration of the collagen solution.

3.2.4 Differential Scanning Calorimetry (DSC)
Collagen fibers were characterized using DSC to ascertain possible changes in
thermal stability caused by CO2 treatment. After CO2 treatment, collagen fibers were
dissolved in 4% v/v (0.7 M) acetic acid to create a collagen solution with 1 mg/mL
collagen concentration. Each solution was degassed for 15 min using a vacuum
desiccator and magnetic stirring bar before testing. After doing a baseline scan of acetic
acid, the degassed collagen solution was carefully added to the sample port of the Nano
DSC (TA Instruments, New Castle, DE). The instrument was pressurized to 3 atm
(gauge) and the sample was heated from 15 to 100°C at a rate of 2°C/min. Data were
recorded and analyzed with the NanoAnalyze software accompanying the instrument.
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3.2.5 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)
After CO2 treatment, collagen fibers were dissolved in 4% acetic acid. Laemmli
sample buffer (Bio-Rad, Hercules, CA), which contained 62.5 mM Tris-HCl (pH 6.8),
2% SDS, 0.01% bromophenol blue, and 25% glycerol, was reduced with βmercaptoethanol (βME) to a βME concentration of 5% and then mixed with the four
collagen solutions: untreated, liquid CO2-treated, scCO2-treated, and thermally denatured
collagen (used as a control). The solutions were heated for 10 min at 80˚C using a water
bath. After cooling to ambient temperature, 10 μg of protein was loaded into the wells of
a 4-15% acrylamide Mini Protean TGX gradient gel (Bio-Rad). Running buffer (TrisGlycine buffer, Bio-Rad) was added and electrophoresis was conducted at a constant 100
V until the dye front approached the bottom of the gel. Precision Dual Color Standards
(Bio-Rad) were used as molecular weight markers in the leftmost well.
After electrophoresis, the gel was separated from the plastic cover and washed
three times with deionized water for 5 min each. The water was decanted and the gel was
stained for 1 hr on an orbital shaker using 50 mL of Coomassie Brilliant Blue R-250 stain
(Bio-Rad). The gel was washed for 30 min in deionized water and then photographed to
observe protein bands.

3.2.6 Circular Dichroism (CD)
The same collagen treatments studied in SDS-PAGE were dissolved in 10 mM
sodium phosphate and studied using a CD spectropolarimeter (Jasco J-815, Oklahoma
City, OK). Collagen solutions were analyzed at concentrations of 10, 15, and 20 μg/mL,
and a thermally-denatured collagen solution was used as a negative control. Nitrogen
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flow set to 10 L/min. After waiting 30 minutes for the xenon lamp to reach full power, 1
mL of each collagen solution was added to a quartz cuvette. CD scans were run at scan
rates of 20 and 50 nm/sec over a 250-190 nm wavelength range. Data were exported to
Excel and saved to a USB drive.

3.2.8 Statistical Analysis
Graphs and tables show the mean value plus or minus one standard deviation. A
Student’s t-test was used to determine statistical differences between groups. 95%
confidence (p < 0.05, indicated by *) was considered statistically significant, while 99%
confidence (p < 0.01, indicated by **) was considered extremely significant.

3.3

Results and Discussion
Though collagen processing and compressed CO2 have each garnered attention in

the TE field, little is known about the fundamentals of how the two interact. In this
study, chemical compatibility of type I collagen with liquid and scCO2 was assessed by
studying changes in thermal stability (DSC), molecular weight (SDS-PAGE), secondary
structure (CD), and water content (vacuum drying). If native collagen is chemically
compatible with either or both CO2 treatments, then applied processing can be explored.
Though chemical compatibility is studied directly, mechanical compatibility can also be
inferred given the temperatures and pressures required for dense-phase CO2 to exist.
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3.3.1 Thermal Stability
For CO2 to be practical in collagen processing, maintaining the thermal stability
of the protein is crucial. If collagen is denatured by heat, the crystalline regions collagen
melt and it loses functionality like any other protein [188, 189]. Native collagen at
mildly acidic pH is reported to denature at temperatures as low as 39-40°C [183]. This
makes scCO2 treatment a concern because treatment at physiologic temperature (37°C)
approaches this threshold.
The thermal stability of treated and native collagen was assessed by DSC. A
sample DSC thermogram of untreated collagen is shown in Figure 3.2. This thermogram
shows two characteristic peaks: a minor peak at 32-33°C and a major peak at 38-40°C,
that were consistently observed in collagen denaturation. This suggests a bimodal
denaturation process, as recently observed by Staicu et al. under similar conditions [190].
They propose that the initial small peak is caused by the disassembly of supramolecular
complexes (i.e. separation of collagen molecules from one another) and the large second
peak indicates the unfolding of each triple helical molecule into a random coil formation.
Table 3.1 shows that scCO2 treatment does not have a significant impact on the
height or temperature of either peak, indicating that the thermal stability of collagen is
not substantially altered by scCO2 treatment. This result indicates thermal compatibility,
likely because the uncharged and nonpolar scCO2 does not disrupt the polar and charged
amino acids in collagen. However, Table 3.1 shows that liquid CO2 treatment
significantly reduces the height of both peaks, and sometimes the smaller peak is not
even observed. This indicates considerable denaturation during treatment.
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Figure 3.2 – Sample Thermogram of Collagen DSC: Thermogram of native collagen in
4% acetic acid, 0.25 mg/mL. The smaller initial peak represents the unfolding of
supramolecular complexes, while the larger peak is the unfolding of the collagen
molecule itself.
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Table 3.1 – Collagen DSC – Native Collagen
Treatment

Minor T (°C)

Native
Supercritical
Liquid

33.1 ± 1.0
33.3 ± 0.3
34.2^ ± N/A

Minor Ht.
(uW)
8.6 ± 2.5
10.4 ± 3.8
3.9^ ± N/A

Major T (°C)
38.5 ± 0.5
38.3 ± 0.6
39.1 ± 0.3

Major Ht.
(uW)
58.6 ± 12.0
47.5 ± 9.7
10.5** ± 6.6

^Peak only observed once; the height value of zero was used for other runs.
** p < 0.01 compared to native collagen
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This finding is surprising, as our previous work with liquid CO2 at room
temperature indicated that crystalline polymers tend to be compatible with liquid CO2
[116]. Furthermore, the liquid CO2 treatment was done at milder conditions than scCO2.
However, the temperature in this work was 10-15°C below room temperature. At first
glance, a temperature difference of only 10-20°C seems unlikely to cause such a drastic
change in thermal stability, but further consideration of collagen chemistry reveals
several consequences of the temperature difference. Temperature is the most notable
factor in protein denaturation, but pH and salt concentration also play a role [191, 192].
Since water is present internally within the collagen structure [179, 193], CO2 forms
carbonic acid in the presence of water, causing a significant pH reduction. Recent studies
have shown that collagen is stable at mild pH but denatures readily at high acidity or
basicity [194]. pH depression by CO2 may be exacerbated at lower temperatures because
the solubility of CO2 in water is inversely proportional with temperature.
Although protein denaturing by heating is done routinely, a similar phenomenon
by cooling, called cold denaturation, also exists for many proteins [195]. Other studies
have shown that long-term freezing of collagen negatively affects its thermal properties,
including reducing its heat denaturing temperature by over a degree Celsius [196]. CO2
density also increases at lower temperatures. However, the liquid CO2 temperature used
in this study was above freezing, and cold denaturation is more commonly observed in
globular proteins [197], so internal pH drop is more likely to be the driving force of the
observed denaturation during liquid CO2 treatment.
It was hypothesized that repeating liquid CO2 treatment at a higher temperature
would significantly reduce or even eliminate collagen denaturation, and preliminary
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research indicates that this is the case. DSC of a collagen fiber treated with liquid CO2 at
25°C indicated much less denaturation (see Appendix A). If raising the process
temperature is not feasible, a basic additive, such as ammonia, could also counteract the
pH drop caused by the interaction of liquid CO2 and water.

3.3.2 Molecular Weight
The effect of CO2 treatment on the molecular weight of collagen was determined
by gel electrophoresis. Native type 1 collagen would be expected to show a doublet at
139 and 129 kDa, indicating the presence of the α-1 and α-2 helices, and possibly to show
a double helix β-band at 258-288 kDa [198]. On Figure 3.3, a band between 150 and
125 kDa is clearly observed for untreated collagen and both CO2 treatments. There is no
Clear band visible above 250 kDa, which indicates that the collagen is broken down into
individual α-helices during the preparation step. Comparison of lanes 3, 5, and 7 to the
large smear (rather than bands) in lane 9 shows that neither CO2 treatment completely
denatures the protein.
Though an α-helix band is clearly observed in Figure 3.3, it is unclear in the
figure if there is one band or two in the 130-140 kDa region. Magnified images of lane 7
are shown in Figure 3.4. A doublet is somewhat observable in image (a), but becomes
very clear upon image enhancement in image (b). As expected, the first band, for the α-1
helix at 139 kDa, is about twice the size of the α-2 band at 129 kDa. Overall, the SDSPAGE results show that both supercritical and liquid CO2 treatment do not have a
significant effect on the molecular weight distribution of collagen.
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Figure 3.3 – SDS-PAGE Gel Stained with Coomassie Blue: Lane 1 – Protein Standards;
Lane 3 – Untreated Collagen; Lane 5 – Supercritical CO2 Treatment; Lane 7 – Liquid
CO2 Treatment; Lane 9 – Thermally-Denatured Collagen
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Figure 3.4 – SDS-PAGE Doublet Close-Up: (a) Original photograph, (b) Enhanced
photograph. N is native collagen, L is liquid CO2 treatment, and SC is scCO2 treatment.
Image (b) was enhanced by adjusting the contrast and color saturation levels in Adobe
Photoshop. Bands are observed for both the α-1 and α-2 helix present in type I collagen
in native collagen and both CO2 treatments. The α-1 band is roughly twice as large
because type I collagen contains two α-1 helices and one α-2 helix.
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3.3.3 Secondary Structure
The effects of CO2 treatment on the secondary structure of collagen were
determined using circular dichroism (CD). Normally, triple-helical collagen has a CD
spectrum with a positive peak at 225 nm and a negative peak at 205 nm [183]. As
collagen denatures, it shifts from helix conformation to a random coil. The same four
treatments used for SDS-PAGE were analyzed by CD in the ultraviolet range (190-250
nm); CD spectra for each treatment at the 15 μg/mL concentration are shown in Figure
3.5 (spectra at other concentrations are available in Appendix B). For native collagen
(blue), a positive peak is observed at 225 nm and a negative peak at 205 nm, as expected.
In contrast, denatured collagen (red) is simply a flat line because denatured collagen has
no secondary structure. Mirroring the DSC findings, scCO2 treatment (green) has very
little impact on the secondary structure, with very similar peak magnitudes and
wavelengths to native collagen. On the other hand, liquid CO2 treatment (yellow) causes
significant changes to the CD spectrum: the magnitude of the positive peak is
considerably less, and the negative peak is barely observable. These changes suggest a
conformational shift toward random coil, since the random coil conformation has a
positive peak near 210 nm that would counteract with the negative peak observed at 205
nm in native collagen [199].
The finding that liquid CO2 disrupts collagen secondary structure may appear to
contradict the SDS-PAGE findings, which indicated no protein damage by liquid CO2
treatment, but this is not the case. CD measures secondary structure, which is clearly
disrupted by liquid CO2 treatment. Proteins studied in SDS-PAGE, however, must be
linearized for bands to form; i.e. their secondary structure must be fully removed
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Figure 3.5 – Circular Dichroism Spectra of Collagen CO2 Treatments: In untreated triple
helical collagen, a positive peak is observed at 225 nm and a negative peak at 205 nm.
Similar results are observed for supercritical CO2 treatment, but response is dampened for
liquid CO2 treatment. Denatured collagen shows no peaks, as expected.

50

(this is done with βME and the 10-minute heating step; see section 3.2.5). Therefore,
one can conclude that liquid CO2 treatment partially denatures collagen – i.e. it is
disruptive enough to affect the secondary structure, but not enough to affect the primary
structure.
It is worth noting the large amount of CD scatter observed at wavelengths below
200 nm. This is a common problem with some CD buffer solutions, where a
considerable amount of noise is encountered in the high frequency part of the ultraviolet
region (usually between 180 and 200 nm). Several attempts were made to reduce this
noise, but they were unsuccessful in reducing the noise while still maintaining sharp
peaks. Fortunately, no characteristic collagen CD peaks are found in the low wavelength
region for either the triple helix or random coil conformations, so the noise did not
meaningfully affect data collection or results interpretation.

3.4

Conclusions
In this chapter, the effects of supercritical and liquid CO2 treatment on the

chemical and physical properties of type I collagen fibers were investigated. Analysis by
differential scanning calorimetry found minimal alteration of collagen thermal stability
by scCO2 treatment, but significant denaturation from liquid CO2 treatment. This
surprising result may be attributable to internal pH drop caused by the low temperature
used during this treatment; preliminary data indicate better compatibility at higher
temperatures.
SDS-PAGE showed no significant changes in collagen molecular weight during
either CO2 treatment, as the characteristic α-helix doublet was observed in both. CD
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spectra of scCO2-treated collagen showed only a small effect on peak height and no
change in peak wavelength, but liquid CO2 treatment caused a significant reduction in
peak height and also shifted the negative peak toward a higher wavelength, indicating a
transition from helical conformation to random coil structure. Again, this finding may be
caused by the treatment temperature used.
In summary, it can be concluded from this study that scCO2 and type I collagen
are chemically compatible, and it would be sensible to consider utilization of scCO2 in
more practical collagen processing applications, such as sterilization, scaffold production,
and extraction of residual crosslinking agents. Liquid CO2 partially denatures collagen at
the conditions studied, though preliminary data indicates that increasing the temperature
could improve compatibility. Since the supercritical phase is generally preferred because
of its superior transport properties, only scCO2 was studied for the remainder of this
dissertation.
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Chapter 4
4.1

Extracting Glutaraldehyde from Crosslinked Collagen with scCO2

Introduction
Since the emergence of TE as a scientific field, collagen has been utilized in TE

scaffolds [180]. Collagen is found ubiquitously throughout the human body and has very
low immunogenicity and antigenicity. Collagen can be molded into scaffolds of various
sizes and morphologies in both the solid and liquid/gel state; some examples of this
include electrospun scaffolds [200], lyophilized collagen [130], and collagen hydrogels
[198]. These methods allow collagen scaffolds to be tailored to have a desired porosity
and permeability. Furthermore, collagen has been proven influential in orchestrating the
adhesion, migration, and proliferation of cells during tissue growth [126]. Collagen
scaffolds also evoke an anti-inflammatory wound healing immune response [4].
However, collagen does have one major weakness as a TE scaffold material: its
lack of mechanical strength. Because of this deficiency, untreated collagen is rarely used
as the sole material in fabrication of TE scaffolds. There are two approaches commonly
utilized to circumvent this problem. The first is blending collagen with another
biomaterial [121]. A number of biomaterials have been used for this purpose, including
natural polymers [201], synthetic polymers [142], carbon nanotubes [145], and ceramics
[144]. This approach increases the mechanical strength, but risks increasing
immunogenicity. It also increases the complexity of scaffold design and post-fabrication
processing steps, such as sterilization and removal of residuals.
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The other approach is crosslinking collagen to augment its mechanical strength.
Crosslinks are covalent bonds formed between adjacent polymer chains that increase the
mechanical strength of a polymer. Such bonding can be photo-activated using ultraviolet
(UV) irradiation, but UV crosslinking can denature proteins and is ineffective for thick
samples because of its non-uniform penetration depth [135]. Chemical crosslinking is
often more effective; in particular, glutaraldehyde is a reagent that has been shown to
achieve a high degree of crosslinking at relatively low concentrations [202]. However,
residual glutaraldehyde is extremely cytotoxic. Speer’s group showed that as little as 3
ppm of glutaraldehyde in cell media can kill over 99% of fibroblasts [137], and
glutaraldehyde is also a known carcinogen [203]. Crosslinked TE structures often must
undergo a rigorous heating process to remove residual reagents; this can be unsuitable for
the physical and biochemical properties of collagen scaffolds [204]. Recently, more
attention has been given to alternative crosslinking agents, such as EDC [138], genipin
[139], and riboflavin [140], but these are relatively unexplored and may be less potent
than glutaraldehyde [141].
If residual glutaraldehyde were removed using a faster and less disruptive method,
it could significantly benefit collagen TE research. The objective of this study was to
develop a process to extract residual glutaraldehyde from crosslinked collagen films
using scCO2. scCO2 is formed when pure CO2 is heated and pressurized above the
critical conditions of 31.1°C and 7.38 MPa. These relatively mild conditions are suitable
for processing biomaterials. In particular, scCO2 has been used to extract numerous
biomolecules, including essential oils [26], caffeine [69], and fatty acids [205]. It has
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also been used in several other biomedical applications, including critical point drying
[57], pasteurization [23, 93], and sterilization [30-32, 34-37].
Recently, Reverchon’s group used scCO2 with an ethanol additive to extract
residual glutaraldehyde from crosslinked chitosan aerogels [41]. They found that an 8
hour CO2 treatment could reduce glutaraldehyde levels below 1 ppm, and in some cases
even below 0.1 ppm. This is a critical finding for gel TE, as the standard heating process
to remove residual glutaraldehyde would exceed the glass transition temperature of the
biomaterial and cause collapse of the aerogel structure. An analogous finding for
collagen TE would be of similar benefit.
Additionally, it was desired to quantify any possible effects or alterations to the
chemical and physical properties of crosslinked collagen caused by scCO2 treatment.
This was accomplished by comparing the thermal stability and mechanical properties of
treated films to untreated films. Maintaining the thermal and mechanical properties of
collagen during glutaraldehyde extraction is important for preserving scaffold
functionality in downstream applications.

4.2

Materials and Methods

4.2.1 Fabrication of Collagen Films
A 1% (w/v) type I collagen dispersion was obtained from the Yost lab; it was
prepared by their group as described previously [4]. Collagen films were prepared
according to the protocol of Weadock et al [206]. 1 M hydrochloric acid was added to 2
mL aliquots of collagen until reaching pH 2. The acidified collagen was poured into a 35
mm diameter petri dish (BD Falcon, Tewksbury, MA), covered with aluminum foil, and
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air-dried in a chemical fume hood for 48 hr. The resulting dried film was then carefully
removed using fine forceps, cut into 2 cm x 0.5 cm rectangular strips, and stored at room
temperature pending further experimentation.

4.2.2 Glutaraldehyde Crosslinking
To crosslink the films, a 25% (v/v) glutaraldehyde solution (TCI America,
Portland, OR) was diluted with deionized water to either 0.25% or 1%, as desired. The
solution was vortexed for 1 min at high speed to ensure uniform mixing, then a collagen
film strip was carefully immersed in the solution. The film and glutaraldehyde solution
were left undisturbed for 72 hr, then the film was removed and washed several times with
deionized water before further treatment.

4.2.3 Glutaraldehyde Extraction using scCO2
Crosslinked collagen films were loaded into the treatment chamber of a twochamber scCO2 flow system, shown in Figure 4.1. The main difference from Figure 3.1
is the addition of a second high-pressure vessel (5). Here, ethanol was mixed with scCO2
until it was fully dissolved (no more than 1 min). Then, the valve to the treatment
chamber (6), which contains the collagen film to be treated (7), was opened, and scCO2
flow was set to 2.5 mL/min (residence time: 4 min). Design of the presaturation system
is discussed in greater detail in Chapter 5.
As done previously, the temperature was maintained at 37°C by the
environmental chamber, (4), and the pressure of the scCO2 in the vessels was maintained
at 20 MPa (2900 psi) using a back-pressure regulator (10). A manual hand pump (8) was
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Figure 4.1 – Glutaraldehyde Extraction Schematic: 1 – CO2 Supply; 2 – High Pressure
Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation Chamber and
Stirring Bar (ethanol additive); 6 – Treatment Chamber; 7 – Collagen Film; 8 – CO2 Hand
Pump; 9 – Pressure Gauge; 10 – Back Pressure Regulator; 11 – Emergency Vent
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used to depressurize the system at a rate of 0.34 MPa/min (50 psi/min). Valves and
fittings rated for pressures up to 68.9 MPa (2) were used throughout the system.
As a control, glutaraldehyde was separately removed from crosslinked collagen films by
heat treatment for 12 hr at 120°C using a vacuum oven according to the protocol of Yang
et al [204].

4.2.4 Measurement of Residual Glutaraldehyde
The concentration of residual glutaraldehyde was measured using a
spectrophotometric method first performed by Bigi et al. [207]. Crosslinked collagen
films were placed in a quartz cuvette (VWR, Radnor, PA) before and after scCO2
treatment. The cuvette contained 3 mL phosphate buffered saline (PBS) with 0.1 M
glycine. The presence of glycine has been shown to counteract the gradual pH drop
normally observed with proteins in PBS solutions.
The cuvette was immediately placed into a UV/visible spectrophotometer
(Beckman-Coulter DU 730, Brea, CA), which was utilized in Kinetic/Time mode to
measure the optical density of the solution at 260 nm every 1 min. Typically,
glutaraldehyde was released from the film over the course of 2-4 hr. Separately, a
standard curve was generated for known concentrations of glutaraldehyde in the
PBS/glycine solution; the standard curve was used to determine the unknown
concentration of residual glutaraldehyde in each collagen film.
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4.2.5 Differential Scanning Calorimetry
Crosslinked collagen films were studied before and after scCO2 treatment using
DSC to analyze their thermal stability. Films were dissolved in 4% acetic acid overnight
under gentle stirring. Collagen solutions were next degassed for 15 min using a vacuum
desiccator and magnetic stirring bar. The degassed collagen solution was pipetted into to
the sample port of the DSC instrument after performing a baseline scan with acetic acid
as the reference solution. The instrument was pressurized to 3 atm (gauge pressure) and
the sample was heated from 10 to 90°C at 2°C/min. Data were obtained using
instrument-associated RunDSC and NanoAnalyze software and then were exported to
Excel for further analysis.

4.2.6 Tensile Testing
A uniaxial tensile test to failure was used to analyze the modulus of elasticity
(MOE) and ultimate tensile strength (UTS) of collagen films before and after scCO2
treatment. Collagen films were loaded onto a Bose 3230 Electroforce Biomechanical
Tester (Bose Corp., Farmingham, MA) and one end was stretched at a rate of 0.01 mm/s
until failure. The accompanying Wintest 4.1 software was used to control the experiment
and collect data, which was exported to Excel for further analysis.

4.2.7 Statistical Analysis
Graphs and tables display the mean value plus or minus one standard deviation.
A Student’s t-test was used to determine statistical differences between groups. 95%
confidence (p < 0.05, *) was considered statistically significant, while 99% confidence
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was considered highly statistically significant (p < 0.01, **). All experiments were
performed in triplicate (n = 3) unless stated otherwise.

4.3

Results and Discussion
Collagen films were prepared, crosslinked with glutaraldehyde, then either used

as controls or treated with scCO2 for 1 hour to extract unreacted glutaraldehyde. Treated
films were examined for extent of glutaraldehyde removal and for any changes in their
physical properties effected by scCO2 treatment.

4.3.1 Glutaraldehyde Extraction
Figure 4.2 shows an example of transient glutaraldehyde release from collagen
films before and after scCO2 treatment. The concentration of glutaraldehyde plateaus
after all residual glutaraldehyde has leached into the glycine solution. In this example, it
is clear that the glutaraldehyde concentration is far greater than the cytotoxic level prior
to scCO2 treatment, but well below it afterwards. Similar behavior was observed in all
other runs. Glutaraldehyde extraction with scCO2 was effective at both crosslinking
concentrations, 0.25% and 1%, as seen in Figure 4.3. Two key findings are noted. First,
and most importantly, scCO2/ethanol treatment removes over 95% of residual
glutaraldehyde at both crosslinking concentrations. The residual glutaraldehyde
concentration after scCO2 treatment is below the reported cytotoxic threshold of 3 ppm in
our experiments, though it should be noted that the magnitude of residual glutaraldehyde
concentration is dependent on the mass of collagen and volume of PBS/glycine solution
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Figure 4.2 – Example Glutaraldehyde Release Curves: Glutaraldehyde leaches from the
collagen films at a linear rate until the concentration plateaus. Far less glutaraldehyde is
present in the collagen film after scCO2 treatment.
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Figure 4.3 – Quantitation of Residual Glutaraldehyde: At both concentrations used,
scCO2 extraction of glutaraldehyde reduces the residual concentration by over 95%.
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used in the experiment. Another interesting observation is that the similarity between the
results observed for 0.25% and 1% glutaraldehyde crosslinking solutions.
One would intuitively expect larger residual glutaraldehyde concentration when a
larger concentration is used during crosslinking, but there are several possible
explanations for this result. For example, there may be surface porosity and/or mass
transfer limitations. Also, the results may be related to extent of crosslinking. It is
possible that all of the glutaraldehyde reacts for both solutions, i.e. neither 0.25% nor 1%
glutaraldehyde is a high enough concentration to fully crosslink collagen. Conversely,
the opposite could also be true – the number of amine crosslinking reaction sites on
collagen are limited [208], so if 0.25% glutaraldehyde fully crosslinks collagen, then
increasing the concentration to 1% will have minimal effect.
In their similar study, Baldino et al. found that increasing the mass of
glutaraldehyde used during crosslinking led to more residual glutaraldehyde in the matrix
after scCO2 treatment (pre-treatment glutaraldehyde concentrations were not reported)
[41]. However, this increase was not significant until an extreme excess of
glutaraldehyde was used, which could indicate incomplete crosslinking at higher
glutaraldehyde concentrations or complete crosslinking even at low glutaraldehyde
concentrations. The validity of these theories, particularly those regarding reaction sites
and extent of crosslinking, are elucidated by studying the physical properties of the
collagen films after scCO2 treatment, especially DSC.
Another result worth further consideration is the rapid glutaraldehyde leaching
observed in this work. For example, Figure 4.2 depicts a trial where most of the residual
glutaraldehyde leaches into the PBS/glycine solution in 60 minutes. This calls into
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question using scCO2 at all when glutaraldehyde can be removed just as quickly by the
leaching method. However, the duration of the leaching process is abnormally fast
compared to other accounts. Glutaraldehyde leaching is very slow when the residual
concentration is below 1 ppm, sometimes taking 24 hr or longer [41, 207]. Such low
glutaraldehyde concentrations are likely necessary to avoid cytotoxicity, as media
concentrations above 3 ppm inhibit 99% of cells and concentrations as low as 0.5 ppm
cause some amount of inhibition [137]. Also, the effects of exposing collagen to PBS
and glycine are not confirmed to be benign; salt in particular can affect the thermal
stability of collagen [192], whereas scCO2 is non-toxic and highly inert. Finally, leaching
of other crosslinking agents, such as genipin or riboflavin, would be even slower since
they are larger molecules than glutaraldehyde. For all these reasons, we believe scCO2
has future viability as a crosslinking aid.

4.3.2 Physical Property Analysis
The effect of scCO2 treatment on collagen film properties was studied using two
analytical methods: DSC to assess changes in thermal stability, and uniaxial tensile
testing to measure alterations in stiffness and tensile strength.
The thermal stability of crosslinked collagen films was studied using DSC; peak
heights and denaturing temperatures of crosslinked collagen in 4% acetic acid are listed
in Table 4.1. Compared to native collagen, crosslinked collagen has a much higher
denaturation temperature and a reduced denaturing peak height. The crosslinking process
increases the thermal stability of the protein by introducing covalent bonds, thereby
requiring a higher temperature to denature the protein. However, the peak height is
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reduced because breaking covalent crosslinks is an exothermic process, while protein
unfolding is endothermic [202]. Table 4.1 reveals that scCO2 treatment does not affect
the thermal stability of crosslinked collagen, but heat treatment reduces both peak height
and denaturation temperature, the former being statistically significant. It is noteworthy
that after crosslinking, thermal collagen denaturation is no longer bimodal and only one
peak is observed. This is observed because in the crosslinked state, the collagen
molecules do not separate from each another before unfolding because they are
covalently bonded by the crosslinks, instead of being associated by electrostatic forces
only [209].
Uniaxial tensile testing was performed to determine the effects of crosslinking
and scCO2 treatment on the mechanical properties of collagen films. The MOE and UTS
for each treatment can be found in Table 4.2. Compared to native collagen, crosslinking
caused a major increase in UTS and a lesser but still significant increase in MOE – this is
expected and confirms the DSC findings that suggest a high extent of crosslinking. The
more interesting result is that for scCO2-treated films, the UTS greatly increased with a
lesser but still significant increase in MOE. A likely explanation for this is dehydration is
the addition of ethanol during scCO2 treatment. Ethanol increases scCO2 polarity,
improving solubility of the polar glutaraldehyde molecule (to our knowledge, solubility
of glutaraldehyde in pure scCO2 is not documented, but chemistry of similar molecules
suggests it is minimal). Though ethanol improves glutaraldehyde solubility, it is also
known to substantially increase extraction of water from biomaterials [43, 54].
The implications of biomaterial dehydration vary considerably depending on the
material treated and the application. In Baldino’s work with chitosan aerogels, for
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Table 4.1: Collagen DSC – Crosslinked Collagen
Film Type

Denaturation Temp. (°C)

Peak Height (μW)

Native

39.1 ± 0.4

30.1 ± 8.4

Crosslinked

63.2** ± 0.2

10.0*± 1.9

Crosslinked + scCO2

63.3** ± 0.5

10.6* ± 2.5

Crosslinked + 12 hr heat

59.7** ± 2.7

3.9^ ± 1.8

* p < 0.05 compared to native collagen
**p < 0.01 compared to native collagen
^p < 0.05 compared to crosslinked control
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Table 4.2: Collagen Film Tensile Test Data
Treatment

Modulus (kPa)

UTS (kPa)

Native Collagen

838 ± 141

12.0 ± 2.7

Glut. Crosslinked (72 hr)

1113 ± 220

281** ± 30

Glut. + SC-CO2

1584* ± 404

1067** ± 211

Glut. + 12 hr heating

N/A^

N/A^

* p < 0.05 compared to native
**p < 0.01 compared to native
^Heat-treated samples were too damaged to be tested
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example, dehydration is probably not a major concern (no mechanical testing was
reported in their study), since air is used to purposely remove water from the gels. In
other applications, such as scaffold production for long-term storage, a dry product is
acceptable or even desirable [210]. However, in a water-rich substrate like a hydrogel,
this drying effect is potentially a major hindrance to scaffold function and/or mechanical
properties [168]. We have developed a method to prevent dehydration of biomaterials
during scCO2 treatment that could be applied to this system to prevent the drying
phenomenon [211]; this method will be discussed in considerable detail in Chapter 5 in
the context of tissue decellularization.
It should be noted that the mechanical test performed has some limitations. The
assumption of a perfectly rectangular geometry used in calculations is not fully accurate
for treated films; the crosslinking and CO2 treatment processes can cause warping around
the edges of the films, distorting the original shape. Also, most tissues undergo more
complex stressed in vivo than the static uniaxial forces applied in this work. Blood
vessels, for example, undergo dynamic biaxial forces in both the axial and longitudinal
directions that vary with regular changes in blood pressure [212]. Therefore, it is
important to assess the mechanical properties of a tissue engineering scaffold or
biomaterial based on the intended application.

4.4

Conclusions
In this chapter, a novel scCO2 method for extracting residual glutaraldehyde from

crosslinked type I collagen films was presented. In one hour of scCO2 treatment, over
95% of unreacted glutaraldehyde was removed from the films, reducing residual
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glutaraldehyde levels below 1 ppm. Very similar results were obtained when 0.25% and
1% glutaraldehyde solutions were used to crosslink the films, likely because all possible
reaction sites were utilized at both concentrations.
After scCO2 treatment, DSC and tensile testing were performed to determine any
potential effects of scCO2 treatment on the thermal and mechanical properties of the
collagen films. The DSC response was essentially unchanged before and after CO2
treatment in terms of both peak height and denaturation temperature, indicating that CO2
treatment did not disrupt the thermal stability of the films. Tensile testing caused a
significant increase in stiffness compared to the control and an even greater increase in
UTS, indicative of supercritical drying caused by the ethanol additive. However, this
finding may not be problematic in some applications, and recent work in our lab indicates
that biomaterial dehydration is easily preventable if desired. The availability of a fast,
innocuous method for removing residual glutaraldehyde from crosslinked collagen films
overcomes a significant problem presented in the collagen TE literature. Moving
forward, it will be important to assess scaffold biocompatibility after scCO2 treatment
and to determine the efficacy of this method for substrates of varying composition,
thickness, and morphology.
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Chapter 5
5.1

Preventing Biomaterial Dehydration with scCO2 Presaturation

Introduction
Currently in the United States, over 120,000 people are on the national waiting

list for an organ transplant, and that number is rapidly increasing [1]. One way to address
this problem is the implantation of artificial tissues and organs fabricated via tissue
engineering (TE), which would reduce wait times and alleviate the current necessity for
tissue and organ donors. However, tissues, organs, and their corresponding extracellular
matrices (ECM) are highly complex and differ considerably throughout the body, making
the development of functional, biocompatible, and sterile biomaterials very challenging.
Potential barriers in the development of both synthetic and naturally-derived scaffolds
include dehydration, loss of mechanical strength, chemical alteration of the matrix
structure, and residual cytotoxicity when some detergents are used [10, 20, 213].
One promising but underexplored method of fabricating TE scaffolds involves
using a SCF as a solvent. In particular, scCO2 is promising for biomedical applications.
It is inexpensive, readily available, chemically inert, nontoxic, and nonflammable [21]. It
has mild critical conditions of 31.1°C and 7.4 MPa, so processing biological materials
can take place at or near physiologic temperature (37°C). Equipment and processes
utilizing scCO2 have already been demonstrated in extraction of biological compounds
[25, 26, 76-78, 80-83], decellularization [43], pasteurization [22-24, 93-95], and in
sterilization of medical devices [33, 104], hydrogels [32], and decellularized ECM [38,
39]. Additionally, scCO2 has been used to aid in hydrogel and polymer foaming [29, 40,
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42], crosslinking of chitosan hydrogels [41], and several other TE scaffold fabrication
methods [109-113].
Because the scCO2 platform has such versatility, it is important to explore the
fundamentals and mechanisms behind the various processes. One issue reported has been
undesired dehydration of biomaterials during scCO2 treatment. Water has a small but
appreciable solubility in scCO2, around 0.01 mole fraction at mild supercritical
conditions [214], which causes gradual dehydration of a material in a dynamic scCO2
system. For example, Sawada et al. used scCO2 to decellularize porcine aorta [43]. They
reported DNA and cellular removal that would be adequate for the preparation of a
naturally-derived TE scaffold, but SCF extraction of volatile substances (primarily water)
during treatment caused embrittlement of the ECM, potentially endangering its viability
as a scaffold. Because hydrogels also have very high water content, understanding and
preventing unwanted water extraction from occurring is of great importance in processing
both synthetic and naturally-derived biomaterials with scCO2.
The reported extraction of volatiles during CO2 treatment is not surprising. In
fact, this phenomenon is well-known and is the basis of critical point drying (CPD), a
process commonly used in tissue engineering [54] and other applications, such as
electronics processing [55] and scanning electron microscopy [57]. The primary
advantage of CPD over conventional evaporative drying is that CPD avoids passing
through the two-phase vapor-liquid region of the phase diagram. Avoiding this region is
desirable for delicate materials that can be damaged by the surface tension that exists at
vapor-liquid interfaces [58]. However, in this application, it is desired to avoid any kind
of drying.
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In this chapter, we address a challenge that will be common to any process,
namely, the unwanted removal of water and volatiles from soft biomaterials. We
hypothesize that dehydration caused by scCO2 treatment can be significantly reduced or
even eliminated by presaturating scCO2 with water prior to treatment. Establishing
thermodynamic equilibrium between water and scCO2 will prevent volatile substances
from being extracted. The objectives of this chapter are as follows: (1) to construct an
apparatus that can presaturate scCO2 with water (i.e. achieve dynamic total solubility of
water), and (2) to compare the amount of water extracted from two model scaffolds, a
poly(acrylic acid-co-acrylamide) hydrogel and porcine aorta tissue, using dry and
presaturated scCO2. Achieving these objectives will enable further development of
scCO2-based TE and decellularization processes.

5.2

Materials and Methods
To prevent water extraction from porcine tissue it is necessary to first achieve

dynamic thermodynamic equilibrium (i.e. complete saturation) between CO2 and water.
The saturated CO2 phase is subsequently suitable for treating a TE matrix. The first
experimental objective was to ensure that the CO2 was being fully saturated during the
mixing process. Achieving this goal is critical before attempting to decellularize a tissue.

5.2.1 Apparatus Development and Validation
A schematic of the presaturation apparatus used is shown in Figure 5.1. The
essential function is to contact flowing scCO2 with liquid water in a temperaturecontrolled, high pressure vessel. The vessel (5) shown in Figure 5.1 is a 25 mL high
pressure stainless steel view cell (Waters Corp., Milford, MA). 10 mL of deionized water
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was added to the vessel prior to the start of each run. The vessel was continuously
agitated using a stirrer plate and magnetic stirring bar. Temperature was maintained at
50°C by the environmental chamber, (4). The pressure of scCO2 in the view cell was
maintained at 13.8 MPa (2000 psi) using a back-pressure regulator (7).
To validate apparatus function, liquid carbon dioxide (1) was compressed in a
chilled syringe pump (3) and slowly bubbled into the high pressure vessel. After waiting
15 minutes for thorough mixing, the humidified scCO2 was then flowed at various rates
(controlled by the syringe pump) through the vessel and then a cold trap (8), which was
maintained at -70°C using an ethanol/dry ice bath to condense dissolved water as the CO2
exited the system.
The mass of the cold trap was measured after each experiment using an analytical
mass balance (Mettler Toledo, Columbus, OH) to determine the amount of water
dissolved in the scCO2 at each flow rate. This process is called the dynamic solubility
method, where one stream is continuously fed into the system and the temperature and
pressure are controlled externally and kept constant [215]. Calibration of this apparatus
required validation that scCO2 would be saturated at sufficiently low scCO2 flow rates. It
is known that as the flow rate of CO2 increases in a dynamic flow apparatus, the
residence time becomes too short for complete presaturation. Trials were conducted at
varying CO2 mass flow rates (1, 2.5, 5, 10, 15, and 20 mL CO2/min; n = 4 for each flow
rate) measured at the pump inlet (0°C, 13.8 MPa; ρCO2 = 0.994 g/mL). Treatment time
was varied for each flow rate to ensure the same mass of scCO2 was used in each trial.
The equilibrium solubility of water in supercritical CO2 at 50°C and 13.8 MPa (ρCO2
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Figure 5.1 – Presaturation Test Schematic: 1 – CO2 Supply; 2 – High Pressure Valve; 3 –
Syringe Pump; 4 – Environmental Chamber; 5 – 25 mL High Pressure Vessel; 6 –
Pressure Gauge; 7 – Back-Pressure Regulator; 8 – Cold Trap
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=0.665 g/mL) was found to be 0.00837 mole fraction by interpolation of known data
[214], and compared to the mole fraction of water dissolved in CO2 at each flow rate to
calculate an observed mole fraction, yobs.

5.2.2 Biomaterial Selection and Preparation
To further investigate presaturation, we studied both a synthetic hydrogel and a
natural tissue, porcine aorta. The hydrogel was poly(acrylic acid-co-acrylamide)
potassium salt (Sigma-Aldrich, St. Louis, MO), a hydrogel used previously to establish
the ability of dense-phase CO2 to achieve sterilization within a porous matrix [32].
Hydrogel powder was hydrated in excess water at 4°C for 24 hr. Excess water was
removed from each hydrogel specimen by drying for 15 minutes under a light vacuum,
using filter paper and a Buchner funnel to remove free saline prior to weighing and
treatment. Each hydrogel specimen was blotted onto a nylon filter and sealed inside the
treatment chamber prior to exposure to scCO2. The weight of each gel specimen was
approximately 0.2 g.
Porcine heart was obtained from a local slaughterhouse, and the aorta was isolated
and surrounding fatty tissue removed. The aortic tissue was cut into rectangles
(approximately 3 cm x 2 cm) and stored in phosphate-buffered saline (PBS) at 4°C for up
to 48 hours prior to use. Each specimen was dried for 15 minutes under a light vacuum
using filter paper and a Buchner funnel. The treatment ratio and other conditions used
(including temperature, pressure, and depressurization rate) were chosen to be very
similar to the conditions used by Sawada et al. to allow for comparison [43]. Drying in a
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vacuum oven (37°C, 38.1 cm Hg vacuum) was used as a negative control; changes in
mass were recorded after 1, 2, 3, 6, and 24 hr.

5.2.3 Treatment of Hydrated Tissue Matrices
All biomaterial treatments were performed using the apparatus shown in Figure
5.2. Compared to Figure 5.1, the primary addition is a second pressure cell, the 10 mL
treatment chamber (6), which contained the biomaterial. Also, a manually-operated
pump (8) (Pressure Generator 62-6-10, High Pressure Equipment Co., Erie, PA) was
connected to the treatment chamber; the manual pump enabled a slow, controlled
depressurization rate of 0.34 MPa/min (50 psi/min) after treatment.
Two treatments were conducted on each biomaterial: one using dry scCO2 (no
water in the presaturation chamber) and the other using scCO2 presaturated with water (n
= 4 for both treatments). All treatments were performed at 13.8 MPa (2000 psi). The
temperature was held constant at either 37°C (ρCO2 = 0.769 g/mL) or 50°C (ρCO2 = 0.665
g/mL, for hydrogel only). Four runs were made at each temperature and state of scCO2
hydration. All biomaterials, regardless of initial mass, were subjected to a treatment ratio
of 60 minutes of scCO2 flow (1 mL CO2/min) per 0.2 g of gel or tissue to account for
small differences in individual masses.

5.2.4 Statistical Analysis
Graphs of data show the mean value plus or minus one standard deviation. A
Student’s t-test was used to determine statistical differences between groups. 95%
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Figure 5.2 – Hydrogel and Tissue Dehydration Test Schematic: 1 – CO2 Supply; 2 – High
Pressure Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation
Chamber; 6 – Treatment Chamber; 7 – Sample; 8 – Hand Pump; 9 – Pressure
Gauge; 10 – Back Pressure Regulator
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confidence (p < 0.05, indicated by *) was considered to be statistically significant; 99%
confidence (p < 0.01, indicated by **) was considered extremely significant.

5.3

Results and Discussion

5.3.1 Verification of Thermodynamic Equilibrium
Validation of the apparatus was demonstrated by using a cold trap to collect
dissolved water in the effluent stream. Validation data are presented in Figure 5.3.
For each CO2 flow rate, an observed water mole fraction (yobs) was calculated from the
moles of water collected in the cold trap and the moles of scCO2 pumped by the syringe
pump. The yobs value was compared to the known equilibrium solubility at the conditions
studied, 0.00837 mole fraction. Complete thermodynamic equilibrium between scCO2
and water was achieved at flow rates of 5 mL CO2/min and below, as measured at the
syringe pump. At flow rates 5 mL/min and below, the effluent water mole fractions
approach the equilibrium limit. As the flow rate increases, the observed mole fraction
decreases, indicating failure to equilibrate. CO2 flow rates of 1 mL/min were used for the
remainder of this work.

5.3.2 Hydrogel Treatment
An important characteristic of tissues and organs is that they are highly hydrated.
Hydrogels have long been studied as a biomaterial for the fabrication of TE scaffolds
because of their high water content, three-dimensional structure, and their ability to be
crosslinked and functionalized [216]. Hydrogels were chosen as a model scaffold for this
study because they are composed primarily of water. Treating a hydrogel with scCO2

78

Figure 5.3 – Validation of Phase Equilibrium: Complete presaturation is achieved at flow
rates less than 5 mL/min.
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allowed us to study the behavior of water and scCO2 in the system without potential
interference from other compounds or variables.
Hydrogels were treated with dry (control) and water-presaturated scCO2 at 13.8
MPa and either 37 and 50°C. Data from these experiments are summarized in Figure 5.4.
At both temperatures, the average water retention was over 99% when scCO2 was
presaturated with water, but only about 50% when dry scCO2 was used.
Results from treating the hydrogel with scCO2 confirm the initial hypothesis. The
hypothesis was also observed visually, as the hydrogels appeared shrunken and partially
collapsed after treatment with dry CO2, as shown in Figure 5.5. The mass retention with
dry scCO2 is slightly lower at 50°C, likely because both water vapor pressure and
solubility in CO2 increase with temperature. With presaturated scCO2, gel mass is
maintained at both temperatures.
One noticeable feature of Figure 5.4 is that the error bars for dry scCO2 treatment
of the hydrogels are relatively large. This is likely related to structural changes in the
hydrogel as it dries. Porous hydrogels like poly(acrylic acid-co-acrylamide) do not dry
uniformly; surface tension effects change the shape of the gel as water molecules are lost
[217]. Additionally, drying curves for this hydrogel were produced by our group in a
previous CO2 sterilization study [32], and a period of sharp mass decline during the
drying process was observed. However, regardless of the specific amount of water lost
during dry scCO2 treatment, Figure 5.4 clearly indicates that presaturating scCO2
prevents water from being extracted from the hydrogels.
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Figure 5.4 – scCO2 Treatment of Hydrogels at 13.8 MPa: Dry scCO2 (blue) extracted a
substantial amount of water, while presaturated scCO2 (red) removed very little.
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Figure 5.5 – Visual Appearance of Treated Hydrogels: (a) untreated hydrogel, (b) hydrogel
treated with dry scCO2, (c) hydrogel treated with presaturated scCO2
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5.3.3 Porcine Aorta Treatment
Vacuum drying was used to produce a complete drying curve for porcine aorta
tissue (n = 6), as shown in Figure 5.6, where dimensionless mass on the y-axis is the ratio
of the mass measured at each time point to the original mass of the tissue. Substantial
water loss occurred during the first six hours, but afterward the loss of mass was
insignificant. Vacuum drying of the native tissue removed over half of the initial mass in
the first hour, with a continually more gradual decline in mass over the next five hours
until reaching slightly above 20% of the initial mass. This is consistent with the known
water content of porcine aorta, which is about 75% [218].
Results for control (dry scCO2) and presaturated scCO2 treatments of porcine
aorta are shown in Figure 5.7. The average mass retentions are 78.6% ± 4.6% with dry
CO2 and 97.3% ± 1.4% with presaturated scCO2; this difference is highly significant. It
is evident from these results that using presaturated scCO2 considerably reduces the
amount of mass lost during treatment, again confirming the initial hypothesis. Visually,
in Figure 5.8, the samples treated with presaturated scCO2 (image b) maintained the beige
color of the native tissue (a), while specimens treated with dry scCO2 (c) experienced
considerable darkening, particularly around the edges of the specimen.
There is still some mass loss using presaturated scCO2, which indicates that a
small amount of volatile substances other than water are extracted from the tissue. This
mass loss may be attributed to other extractable materials in the tissue. While the aorta is
primarily composed of water and polymeric materials like collagen and elastin, there are
other materials present in trace amounts that may be extractable by scCO2. Like most
tissues, porcine aorta is known to contain lipids such as cholesterol [218]; these may
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Figure 5.6 – Vacuum Drying of Porcine Aorta: Conditions were 37°C, 38.1 cm Hg (15 in.
Hg) vacuum; over half the tissue mass was lost in the first hour.
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Figure 5.7 – scCO2 Treatment of Porcine Aorta at 37°C, 13.8 MPa: Using presaturated CO2
significantly increases mass retention.
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Figure 5.8 – Visual Appearance of Treated Porcine Aorta. (a) untreated aorta; (b) aorta
treated with presaturated CO2; (c) aorta treated with dry CO2; (d) vacuum-dried aorta
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TE scaffold. However, this has been done either with a scaffold material other than a
decellularized tissue [41], and/or was done with the intention of long-term scaffold
storage [120, 210]. After long-term storage, a scaffold would require rehydration before
comprise the non-water extracted volatiles in the tissue, as scCO2 has been shown to be
efficacious for the extraction of fatty acids and other lipids [205]. For further
development, any additional volatiles of interest could be identified and, if maintaining
their presence is important, removal could be prevented by pre-equilibration of scCO2,
analogous to pre-equilibration with water.
scCO2 treatment was found to cause less water removal than vacuum drying –
Figure 5.9 shows where dry and presaturated scCO2 treatment lies on the vacuum drying
curve. Even dry scCO2 treatment causes much less drying than a vacuum treatment over
the same time interval. This finding was also confirmed visually, as shown in image (d)
of Figure 5.8. Vacuum drying caused tissues to become significantly darker in color,
similar to dry scCO2 (image c), but also made the tissue far more brittle and translucent.
As indicated by the square on Figure 5.9, only about one-third of the native water
was extracted by dry CO2 treatment. scCO2 drying is less severe than oven drying for
two reasons. First, the flowing scCO2 never allows equilibrium to be established between
the fluid phase and the tissue matrix. There is also mass transfer resistance within the
tissue, which slows transfer of water from the tissue to the flowing scCO2. However,
though scCO2 drying is less pronounced than vacuum drying, unintentional water
extraction on this level could still significantly hamper the effectiveness of a TE scaffold,
so minimizing any drying caused by scCO2 is very important.
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Figure 5.9 – Comparison of Vacuum Drying and scCO2 Treatment of Porcine Aorta. The
square represents the average tissue dehydration run with 1 hour of presaturated scCO2
treatment (0.97), while the circle represents the average tissue dehydration run with 1
hour of dry scCO2 treatment (0.78). Both values are significantly larger than 1 hour of
vacuum drying (0.46).

88

Finally, it should be noted that this work is focused on preventing unintentional
drying during scCO2 treatment, and we are not making the claim that any scaffold dried
during a scCO2 process or otherwise is immediately invalid or nonviable. In fact, work
has recently been published by other groups where scCO2 is used to intentionally dry a
seeding and implantation. In addition to adding another processing step, the rehydration
process has been shown to not fully restore the original water content of the matrix
because of irreversible changes in ECM microstructure [43, 210]. Therefore, we
maintain that in producing a decellularized tissue for immediate use as a TE scaffold, it
would be preferable to retain the original hydration state of the tissue after treatment.

5.4

Conclusions
A novel method for treating hydrogels, tissues, and other hydrated biomaterials

with presaturated scCO2 is presented. The method eliminates or heavily reduces the
extraction of water and other volatiles that has been observed during scCO2 treatment of
biomaterials. In the model biomaterial studies, it was determined that dry scCO2 extracts
considerably more water from hydrogels and tissues than presaturated scCO2. It was also
determined that dry scCO2 treatment removes water from tissues more slowly than
vacuum drying, but that the amount of water extracted by dry scCO2 is still enough to
potentially alter the properties of a hydrated TE scaffold. Even presaturated scCO2 does
extract some volatile components from the tissue, though further analysis is required to
verify this.
From these observations, we conclude that presaturation of scCO2 can be used to
prevent undesired dehydration of biomaterials for TE applications, allowing treated
biomaterials to be used immediately instead of requiring a rehydration step. Having
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overcome this obstacle, further investigation into scCO2-based fabrication of tissue
engineering scaffolds is warranted, including decellularization of natural tissues.
Maintaining properties such as porosity and mechanical strength will be important as this
technology is further developed.
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Chapter 6
6.1

Decellularization of Porcine Aorta Using Supercritical CO2

Introduction
Over 8,000 Americans die annually while awaiting an organ transplant, and

currently over 120,000 Americans are on the national waiting list. Furthermore, the
average wait time to obtain an organ transplant is several years [1]. One way to address
this problem is by replacing damaged tissues and organs with ones created by tissue
engineering (TE), which could greatly reduce transplant wait times and also alleviate the
current dearth of available organ donors. However, tissues and organs are extraordinarily
nuanced and complicated structures, which creates numerous criteria for developing
effective biomimetic materials.
Whether derived from synthetic or natural materials, TE scaffolds must be sterile,
porous, mechanically strong, biocompatible, and of appropriate stiffness and surface
chemistry for the application at hand [2]. Additionally, scaffold fabrication can introduce
numerous mechanical and biochemical deficiencies, including loss of mechanical
strength, loss of surface activity, denaturation of extracellular matrix (ECM) proteins,
scaffold dehydration, and residually cytotoxic solvents, detergents, and/or crosslinking
agents [47]. All of these challenges require novel and innovative TE scaffold fabrication
methods to be continually developed and refined.
Additionally, TE scaffolds must direct cell proliferation and differentiation during
tissue growth. This is a particular strength of naturally-derived biomaterials, which have
recently been shown to promote constructive remodeling during tissue growth [7]. In
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particular, scaffolds prepared from decellularized tissues are uniquely able to receive and
transmit signals to cells, an interaction called dynamic reciprocity [125]. Acellular ECM
scaffolds have also been shown to elicit an anti-inflammatory immune response, which
may be related to a reduced risk of immune rejection [5].
Decellularization is accomplished using a variety of different techniques,
including physical [15], chemical [219], and enzymatic treatment [163]. Treatment with
aqueous detergents, such as sodium dodecyl sulfate (SDS) and Triton X-100, is most
common. Detergents lyse cell and nuclear membranes, but also denature proteins, which
often leads to thorough cell removal but can also disrupt glycosaminoglycans (GAGs),
growth factors, and ECM ultrastructure [13]. Because of these hazards, it has become
common for protocols to use detergents at very low concentrations over several days or
even weeks, minimizing ECM damage while eventually removing all cells [17]. Though
this approach is effective, novel methods are desired to decellularize tissues as effectively
but with shorter treatment times and without using harsh chemicals or solvents for long
periods.
One relatively unexplored method worthy of consideration is treatment with
supercritical carbon dioxide (scCO2). scCO2 is non-toxic, non-flammable, and relatively
inert. Its mild critical temperature (31.1°C) makes it viable physiologic temperatures,
and it has desirable transport properties such as high diffusivity, relatively high density,
and low viscosity [21]. scCO2 has been used extensively in TE applications that involve
synthetic materials, particularly in polymer foaming, where CO2 is used to fabricate TE
scaffolds from synthetic polymers [27-29]. scCO2 has also been utilized in other
biomedical applications, including extraction of biologically-relevant molecules [25, 26],
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critical point drying [57], pasteurization [22-24], and sterilization of biomaterials and
medical devices [30-37].
A novel decellularization technique using scCO2 offers considerably faster
decellularization, on the order of hours instead of days. The absence of harsh chemicals
or solvents could also mitigate damage to the ECM. In 2008, Sawada et al. used scCO2
to decellularize porcine aorta, but dehydration of the scaffold during treatment prevented
further progress [43]. In Chapter 5, we presented a method, presaturation of scCO2 with
water, that greatly reduces tissue dehydration during scCO2 treatment [211].
Our broad aim is to develop a novel scCO2 decellularization method that also
maintains the hydration state of the treated tissue. The objectives of this chapter are: (1)
to examine the extent of decellularization in porcine aorta using scCO2 with different
additives, pretreatments, and thermodynamic conditions; and (2) to present a hybrid
detergent/scCO2 treatment that decellularizes the tissue more quickly and as effectively
as a standard detergent treatment. Achieving these objectives will enable further
development of CO2-based decellularization and TE processes.

6.2

Materials and Methods

6.2.1 Tissue Procurement and Standard Detergent Treatment
Porcine aorta was obtained from a local abattoir, rinsed with PBS and cut into
ring-shaped sections measuring about 1 cm in length. Specimens were stored at -20°C
for up to 48 hr until being treated with scCO2 or a standard SDS treatment.
The standard SDS treatment (treatment “S”; all treatments are listed in Table 6.1)
was performed according to the protocol of Funamoto et al [171]. Tissues were
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Table 6.1: List of Decellularization Treatments
Treatment Name
A
B
C
D
S
H

Treatment Description
1 hr scCO2 with added water
1 hr scCO2 with added water & Ls-54
1 hr scCO2 with added ethanol
1 hr scCO2 with added water & ethanol
48 hr SDS/enzymes + 24 hr PBS wash (“standard treatment”)
48 hr SDS/enzymes + 1 hr scCO2 “wash” (“hybrid treatment”)
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pretreated for 1 hr in a solution containing 0.2% (w/v) EDTA and 10 mM pH 8 Tris
buffer to increase cell membrane permeability. They were then decellularized for
48 hr under light agitation in 0.1% (v/v) SDS, 10 mM Tris buffer, 0.2 mg/mL DNase I,
and 0.02 mg/mL RNase A. Specimens were washed with PBS several times over the
course of 24 hr to remove cell debris and residual detergent; thus the total time required
for decellularization was 72 hours.

6.2.2 Decellularization with Supercritical CO2
The aorta specimen (8) was loaded into the treatment chamber (7) of the scCO2
apparatus, shown in Figure 6.1. The apparatus contained valves and fittings rated for
high pressures up to 68.9 MPa (2). Liquid carbon dioxide (1) was compressed in a
chilled syringe pump (3) and slowly bubbled into the presaturation chamber (5) to
maximize mass transfer. In this chamber, the additive and scCO2 were stirred vigorously
until reaching thermodynamic equilibrium (10-15 min with water and water solutions, 12 min for pure ethanol). Four different additive solutions were used to determine whether
aqueous additives enhanced decellularization: (treatment “A") water, (“B”) water +
Dehypon Ls-54 surfactant (BASF America, Florham Park, NJ), (“C”) ethanol, and (“D”)
water + ethanol.
Once equilibrium was reached, the valve to the treatment chamber was opened,
and scCO2 flow was programmed to 1 mL/min at the pump inlet. During treatment, the
environmental chamber (4) was used to maintain the temperature at either 10 or 37°C,
and a back-pressure regulator (11) was used to keep the pressure of the scCO2 in the
vessels constant at either 10.3 or 27.6 MPa (1500 or 4000 psi, respectively). A manual

95

Figure 6.1 – Supercritical CO2 Decellularization Schematic: 1 – CO2 Cylinder; 2 – High
Pressure Valve; 3 – Syringe Pump; 4 – Environmental Chamber; 5 – Presaturation
Chamber; 6 – Stirring Bar & Additive Solution 7 – Treatment Chamber; 8 – Aorta
Specimen; 9 – Pressure Gauge; 10 – Hand Pump; 11 – Back Pressure Regulator
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hand pump (10) was used to depressurize the system at a rate of 0.34 MPa/min (50
psi/min).

6.2.3 Hematoxylin and Eosin (H&E) Staining
After treatment, tissues were fixed in 10% neutral buffered formalin for at least 24
hr and embedded in paraffin. Tissues were then cut into 5 μm sections using a microtome
and deparaffinized by immersion in xylene (3 times), 100% ethanol, 95% ethanol, 80%
ethanol, and finally water. The tissues were stained with hematoxylin for 7 minutes,
washed with water and ammonia, and then stained with eosin for 2 minutes before being
dehydrated by immersion in 80% ethanol, 95% ethanol, 100% ethanol, and finally xylene
(3 times). A coverslip was mounted on slides, which were then viewed using a light
microscope (Nikon E600, Tokyo, Japan) after waiting at least 24 hr for the slides to dry.

6.2.4 DNA Quantitation
DNA was quantified using the DNAzol reagent kit (Invitrogen, Carlsbad, CA)
according to the prescribed protocol with minor changes. 25 mg of dry aorta were flashfrozen in liquid nitrogen and ground with a mortar and pestle. Specimens were then
placed in a 2 mL tissue homogenizer (VWR International, Radnor, PA) with 0.5 mL of
DNAzol reagent and ground for 5-10 strokes or until fully dissolved. The solution was
then centrifuged at 10,000 x g for 10 minutes and the supernatant was recovered. 0.25
mL of 100% ethanol was added to precipitate the DNA, which was recovered and washed
twice with 70% ethanol for 1 min per wash. DNA was air-dried for 5 sec and redissolved in 4 mM sodium hydroxide (pH 9). Optical density was measured at 260 nm
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using a spectrophotometer (DU 730 model, Beckman-Coulter, Brea, CA) and the DNA
concentration was calculated based on the absorbance measurement and initial mass of
the tissue

6.2.5 Basic Physical Characterization
Aorta specimens from treatments A, B, C, and D were weighed before and after
scCO2 treatment using an analytical mass balance (Mettler Toledo, Columbus, OH) and
compared to the mass of untreated samples and to each other. Additionally, samples
were photographed with a digital camera (PowerShot SX500, Canon Inc., Tokyo, Japan)
and analyzed for changes in size, color, and overall appearance.

6.2.6 Scanning Electron Microscopy (SEM)
After treatments C and D, samples were crosslinked with 2% glutaraldehyde (TCI
America, Portland, OR) in 0.1 M sodium cacodylate buffer, pH 7.2 (Fisher Scientific,
Hampton, NH), overnight at 4°C. The sample was then washed 5 times in 0.1 M
cacodylate buffer (pH 7.2) for 1-2 min each and then post-fixed in 1% osmium tetroxide
(Fisher) for 1 hr at 4°C. After secondary fixing, the specimen was washed 3 times in
cacodylate buffer and then dehydrated in gradually increasing ethanol rinses (50%, 70%,
80%, and 95%) for 10 min each and finally rinsed twice in 100% ethanol for 10 min per
wash to fully dehydrate the specimen.
Specimens were then transferred into microporous vials, immersed in ethanol, and
placed in a critical point dryer (CPD3 – Ladd Research Industries, Williston, VT).
During critical point drying, the sample was submerged in liquid CO2 at 6.2 MPa (900
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psi) at 10°C and the temperature was gradually increased to 40°C, reaching the
supercritical CO2 state. The pressure was then decreased to atmospheric at a rate of 0.69
MPa/min (100 psi/min). Dried specimens were mounted on a stub and coated with gold
twice using a sputter coater (Denton Vacuum, Moorestown, NJ) and then loaded into the
SEM. The SEM used was the Vega3 SBU (Tescan, Brno, Czech Republic) and was used
at a working voltage of 10 kV.

6.2.7 Hybrid SDS/CO2 Treatment
After analyzing the results of the above treatments, development of a hybrid
detergent/scCO2 treatment was desired. The hybrid treatment (“H”) involved exposure of
tissue to the standard detergent treatment solution described in section 6.2.1, followed by
1 hr scCO2 treatment described in section 6.2.2 in lieu of the PBS wash. Water and
ethanol were used together as additives.

6.2.8 Mechanical Testing
The mechanical properties of aorta specimens from treatments S, C, and H were
examined using a uniaxial ring test as described by Twal et al. [220]. Annular samples
were mounted onto a Bose Electroforce 3230 Biomechanical Tester (Bose Corp.,
Farmingham, MA) using two parallel cannulas. Specimens were subjected to three
preconditioning cycles at a rate of 0.05 mm/s with a maximum stretch ratio of 1.2 during
each cycle. Samples were kept moist with PBS during preconditioning to prevent
dehydration. At the start of the identical fourth cycle, load and displacement data were
recorded at a rate of 50 points/sec using the accompanying Wintest software.
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6.2.9 Residual SDS Quantitation
Residual SDS from the standard and hybrid treatments was quantified using an
SDS Detection and Estimation Kit (G Biosciences, St. Louis, MO). The assay involved
mixing 1 mL methylene blue dye with 0.5 mL extraction buffer and 5 μL of aqueous
solution containing SDS, then vortexing for 30 seconds. 1 mL of chloroform was then
added, then the mixture was vortexed again for 30 seconds. Methylene blue is extracted
into the organic phase if SDS is present. After waiting 5 minutes, the bottom chloroform
phase was sampled and optical density was measured at 600 nm. SDS concentration was
calculated by comparison to a standard curve.

6.2.10 Statistical Analysis
Numerical data is presented as mean values plus or minus one standard deviation.
A Student’s t-test was used to analyze confidence in statistical differences between
groups. 95% confidence (p < 0.05, indicated by *) was considered to be statistically
significant, while 99% confidence (p < 0.01, **) was considered highly significant.

6.3

Results and Discussion
The objective of decellularization is to maximize removal of cells and cellular

debris while minimizing alteration done to the ECM during treatment [13]. A successful
decellularization protocol utilizing scCO2 would quicken the process considerably and
could do so using a benign solvent that leaves no residual material in the matrix.
Currently, there is no universally-accepted standard for evaluating the extent of
decellularization. This is not surprising, because tissues vary greatly in stiffness, cell
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density, ECM composition, and numerous other characteristics. Therefore,
decellularization processes must be tailored to the specific tissue of interest [122].
However, Badylak’s group recently proposed a list of three criteria that can adequately
describe a decellularized tissue of any kind. They are [12]:
1. Lack of visible nuclear material in H&E and/or DAPI-stained sections
2. Total amount of double-stranded DNA less than 0.05 μg/mg dry tissue
3. No individual DNA fragment longer than 200 base pairs
In this study, we focused on the first two criteria by performing H&E staining and DNA
quantitation on porcine aorta after scCO2 treatment.
Six different treatments of porcine aorta were undertaken to determine the extent
of decellularization. They included two controls: SDS treatment and treatment with dry
scCO2, and treatment with presaturated scCO2 using four different additive mixtures:
water, water/Ls-54, ethanol, and water/ethanol. The thermodynamic conditions chosen
were based on the factorial design and process optimization performed in Sawada’s work
[43].

6.3.1 Extent of Decellularization with scCO2 – Histology
Tissue sections from each treatment were stained with hematoxylin and eosin
(H&E) and observed under an optical microscope. Hematoxylin is a basic, positively
charged stain that binds to the acidic, negatively charged nuclear envelope and chromatin,
staining it black or purple. Eosin is an acidic, negatively charged stain that binds to
positively-charged ECM proteins like elastin and collagen. There were three controls in
this study: the untreated tissue as a negative control, and the SDS-treated tissue and dry
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Figure 6.2 – Histology of Control Specimens: H&E stained sections of untreated (a),
SDS-treated (b), and dry scCO2-treated (c) porcine aorta. Scale bars represent 50 μm.
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CO2-treated tissue as positive controls.
Sections from the tunica media of each of the controls can be seen in Figure 6.2.
In the native tissue (image a on the figure), the elastic fibers of the ECM are parallel with
regular spacing between them. Round or elliptical whole smooth muscle cells are
attached to the elastic fibers. The middle image on the figure (b) shows the same tissue
after treatment with SDS and a PBS wash. Few intact cells are visible, indicating some
degree of disruption. However, dark, irregularly-shaped areas of cellular debris are
observed, indicating incomplete cell removal. Additionally, significant damage to the
ECM fibers is evident based on their widespread breakage and deformation. Tissue
treated with dry (pure) scCO2 (image c) primarily has intact, undisturbed cells like the
native tissue, though a few cells appear to be shriveled or completely removed based on
the empty space in the micrographs. Elastic fibers are disturbed somewhat, as some
shrinkage is observed and the spacing between fibers is less uniform, but unlike the SDS
treatment, the fibers are not entirely broken.
These findings can be explained by considering the known mechanisms of how
detergents and supercritical fluids interact with cells and proteins. The SDS results
mirror the literature; it is well-known that most ionic detergents, including SDS, can
disrupt both the cell and nuclear membranes by replacing molecules in the lipid bilayer
via the micelle effect [13]. This effect leads to intracellular contents exiting the confines
of the cell and leaving the black, irregular areas of cellular debris found in the
micrographs. However, SDS alone does not remove the cellular debris from the matrix;
debris is usually removed by prolonged washing with a saline solution. In this work,
washing with PBS was done for a relatively brief 24 hr according to Funamoto’s protocol
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[171], but Simionescu’s group and others have shown that saline rinses often require
several days or even weeks to remove all residual cellular material and detergent from a
decellularized blood vessel [17]. It is also well-documented that SDS denatures proteins,
so the shrinkage and cleavage of elastic fibers is not surprising.
Treatment with dry scCO2 was much less disruptive to elastic fibers in the ECM
than SDS treatment. Though no breakage was observed, there is still a clear loss of
uniformity in both fiber size and spacing. This is a reasonable outcome, given that tissue
dehydration is a known effect of dry scCO2 treatment. However, pure scCO2 was
ineffective at removing cells from the matrix. This outcome matches previous
observations by Sawada’s group that scCO2 is ineffective at cell removal without an
additive [43]. Though there is a currently a clear lack of experimental proof, it has been
proposed that the mechanism of scCO2 decellularization is extraction of both whole cells
and cellular debris [12]. Because these materials are charged, dissolution in pure scCO2
is minimal because carbon dioxide is a nonpolar molecule. This suggests using a polar,
CO2-soluble additive to aid in decellularization, as described in the following.
Four different additives were used to presaturate scCO2 in an attempt to improve
cell removal: water (A), water + Ls-54 (B), ethanol (C), and water + ethanol (D). H&E
sections from treatments A and B are shown in Figure 6.3 alongside the untreated tissue.
With regard to decellularization, there appears to be no more removal than with dry
scCO2 (Figure 6.2c). This is not surprising, because although water is polar, it has
relatively low solubility in scCO2 (less than 0.01 mole fraction at the conditions studied)
[214], meaning that the humidified CO2 still is highly nonpolar and unlikely to extract
polar components. Using water as an additive does appear to improve the continuity and
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Figure 6.3 – Histology of Water and Water/Ls-54 Additives: H&E stained sections of
untreated (a), water/scCO2-treated (b), and water/Ls-54/scCO2-treated (c) porcine aorta.
Scale bars represent 50 μm.
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uniformity of elastic fibers, which makes sense since the tissue is not dehydrated by this
treatment.
Figure 6.3 also shows the effect of adding Ls-54 to the solution to be minimal.
Ls-54 is a non-fluorinated surfactant that has been shown to have solubility in densephase CO2 and water (about 0.001-0.005 mole fraction) and to be an effective additive for
removing bacterial endotoxin from a solid surface [103, 104]. However, it appears to be
ineffective in enhancing decellularization, probably because its chemistry differs from
SDS despite them both being surfactants. Though their alkyl chain lengths are similar,
Ls-54 contains a hydroxyl group at the end of its chain rather than the highly dissociative
sodium ion of SDS. Ls-54 also contains several ethoxyl and propoxyl groups, whereas
SDS has a long, nonfunctionalized alkyl chain. These characteristics give SDS
amphiphilic properties that interact with the lipid bilayer in cell membranes much more
readily than Ls-54.
The ineffectiveness of Ls-54 could also be related to treatment temperature. Past
work has shown an inverse proportionality between temperature and Ls-54 solubility in
CO2, including into the liquid CO2 phase [105]. Treatment B was also conducted at
10°C, where CO2 is more dense and exists in the liquid phase at the treatment pressure,
but no significant changes in extent of decellularization were observed (Figure 6.4).
While it is generally expected that thermodynamic conditions will affect the extent of
decellularization, it is likely that this particular treatment is so far from achieving
complete decellularization that these effects cannot be ascertained at this magnification.
To further increase the polarity of the scCO2 mixture, two final treatments were
investigated, using ethanol and ethanol/water as additive solutions. Figure 6.5 displays
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Figure 6.4 – Effect of Thermodynamic Conditions on Extent of Decellularization: H&E
stained sections with water/Ls-54 as the additive solution at the three different
thermodynamic conditions: (a) low density (10.3 MPa, 37°C), (b) medium density (27.6
MPa, 37°C), and (c) high density (27.6 MPa, 10°C). No significant changes in extent of
decellularization were observed between treatments. Scale bars represent 50 μm.
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Figure 6.5 - Histology of Ethanol and Ethanol/Water Additives – H&E stained sections of
untreated (a), ethanol/scCO2-treated (b), and ethanol/water/scCO2-treated (c) porcine
aorta. Scale bars represent 50 μm.

108

H&E-stained sections from these treatments. Treatment with ethanol alone shows
considerable shriveling and branching of the elastic fibers, as was expected. However,
the use of ethanol does not aid considerably in cell removal. Though some of the areas
where the ECM is damaged have fewer cells, the intact elastic fibers have numerous
intact cells attached to them. The addition of water to the ethanol does not markedly
change the extent of decellularization, but does significantly improve the condition of the
elastic fibers. This finding is expected based on Figure 6.3 and the findings of Chapter 5;
the primary objective of using water as an additive is to prevent dehydration, not to
remove cells. Overall, the three treatments that included water as an additive were
notably more effective in maintaining the alignment of the elastic fibers than ethanol
alone. This supports findings in our previous work, which showed that presaturating
scCO2 with water before treatment prevents dehydration of the ECM during scCO2
treatment.
On the contrary, when ethanol is the only additive, shriveling and fraying of the
ECM fibers is observed, as in Sawada’s paper. These findings were also confirmed
visually and by manual handling, as treatment clearly increased the rigidity of the matrix
when water was not added, while the addition of water maintained the apparent flexibility
and pliability of the material. Though interesting, the prevention of tissue dehydration is
made impractical by the lack of cell removal in any of the experiments.
The physical properties of treatments A, B, C, and D were analyzed by mass
measurement, photography, and scanning electron microscopy (SEM). These findings
were rendered impractical by the lack of decellularization, but have been preserved in
Appendix C for the sake of completeness.
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6.3.2 Extent of Decellularization with scCO2 – DNA Quantitation
Ultimately, microscopy indicates only very limited cell removal with the four
scCO2 + additive treatments, and not nearly enough to indicate decellularization. To
confirm visual microscopy results, we employed quantitation of DNA as a measure of
decellularization; one of the proposed criteria for establishing decellularization is a
double-stranded DNA concentration below 0.05 μg DNA/mg dry tissue [12]. For each
treatment in this study, DNA was extracted and its concentration was calculated based on
spectrophotometric absorbance readings. Results of DNA quantitation are shown in
Figure 6.6. All treatments show some amount of DNA removal compared to the
untreated tissue. However, no treatments aside from the standard SDS method approach
the target maximum concentration of 0.05 μg DNA/mg dry tissue.
The results of DNA quantitation follow the histological findings, where SDS was
required in some capacity to rupture cell membranes and attain at least an appreciable
amount of cell removal. The four scCO2 additives do reduce the DNA content compared
to the untreated tissue, though none of the treatments approach complete
decellularization, as with the H&E findings.
The failure of the scCO2/ethanol mixture to decellularize is the most surprising
result, given that this finding is in direct opposition to the findings of Sawada’s group and
that the experiments and the apparatuses used in both studies are both similar. While
there may be unknown differences in equipment or specimens that create a significant
difference between the studies, our results lead us to question Sawada’s findings. When
analyzing the results of an experiment, particularly one where mechanistic steps cannot
be viewed in situ, it is imperative to consider the underlying mechanisms to glean
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Figure 6.6 - DNA Quantitation: Standard & scCO2 Treatments: Values below the red line
(0.05 μg DNA/mg dry tissue) would indicate complete decellularization. All treatments
showed significant DNA removal compared to the control, but none neared adequate
decellularization except for the SDS treatment.
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information about what is physically occurring during the experiment.
The limited discussion in the literature on scCO2 interaction with cell membranes
includes two possibilities: supercritical extraction of cells or cellular debris as a primary
mechanism, and physical dislodging of cells from the ECM caused by high pressure.
Based on our findings, we do not expect the high pressure alone to remove cells; other
work has been published where blood vessels have been decellularized with high
hydrostatic pressure – pressures on the order of several hundred MPa – and cells still
require long-term continuous washing to be removed in these applications [171]. This
suggests renewed focus on the extraction mechanism.

6.3.3 SDS/scCO2 Hybrid Treatment for Decellularization
Earlier in this chapter, the ineffectiveness of Ls-54 surfactant in decellularization
was discussed, possibly because of its inability to permeate the cell membrane. We
theorized that scCO2 in general may suffer from this same problem. To test this
hypothesis, a two-step hybrid SDS/CO2 decellularization treatment was investigated.
With this treatment, tissues were treated with SDS as described in section 6.2.1, but
without the subsequent PBS wash. Instead, tissues were then treated (washed) for 1 hr
with scCO2 presaturated with ethanol and water at the same thermodynamic conditions
used previously.
The effect of the hybrid treatment can be seen in Figure 6.7. Using this hybrid
approach, there are no visible intact cells or cellular debris. Therefore, it is likely that the
tissue is fully decellularized. This is an exciting and intriguing result that suggests polar
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Figure 6.7 – Histology of Hybrid Treatment: H&E stained sections of untreated (a), SDStreated (b), and SDS/scCO2-treated (c) porcine aorta. Image (c) shows complete
decellularization. Scale bars represent 50 μm.
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supercritical CO2 will extract intracellular debris, but cannot do so unless another agent is
used to enhance membrane permeation or rupture. Significantly, the ECM fibers appear
to be intact and mostly undisturbed compared to the complete SDS treatment.
Maintenance of fiber integrity may be a result of shorter exposure time to SDS; the
scCO2/water + ethanol “wash” takes only an hour instead of the day or more required for
PBS washing.
DNA quantitation from the hybrid method, along with the results of the other
treatments, can be seen in Figure 6.8. The figure shows a level of DNA removal similar
to the standard SDS treatment, below the threshold for decellularization with a
concentration of 0.036 μg DNA/mg dry tissue. This is a very exciting result, as the
hybrid method is able to achieve the original objective: to decellularize effectively while
avoiding dehydration of the tissue.
It should be noted that the DNA test performed has sensitivity limitations with the
spectrophotometer used. Optical density near the decellularization threshold is very low,
approaching the tolerance of the instrument. Thus, some error may be present in the
numerical value of the DNA concentration for SDS-containing treatments. However, the
histological results and statistical comparison to the other treatments confirm the efficacy
of the method.
To analyze the physical properties of treated aorta, uniaxial tensile testing was
performed on samples from selected scCO2 treatments (S, C, and H). Stress responses
for each treatment are plotted against stretch ratio on Figure 6.9. The bimodal stress
response seen for each treatment in the figure is normally observed when blood vessel
tissue is subjected to a uniaxial ring test [220, 221]. The first linear segment, observed
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Figure 6.8 – DNA Quantitation including Hybrid Treatment: Bar chart displaying the
DNA content of each detergent and scCO2 additive treatment. Values below the red line
(0.05 μg/mg) indicate adequate decellularization according to Crapo’s standard.
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Figure 6.9 – Uniaxial Ring Test of Treated Aortas: Compared to native aortas (blue), C
treatments (scCO2 plus ethanol, purple) have a sharper stress response while the response
after standard SDS treatments (red) have a flatter slope. The SDS/scCO2 hybrid
treatments (green) are most similar to the untreated aorta.
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for stretch ratios from about 1.0-1.08, is primarily governed by elastin. The response of
the second linear segment, observed for stretch ratios from 1.12-1.2, is governed by
collagen. Contributions to modulus of elasticity by both collagen and elastin were
calculated for each treatment and are listed on Table 6.2. As expected, SDS exposure
denatures proteins and reduces stiffness, while treatment with scCO2 and ethanol causes a
significant increase in stiffness because of dehydration. Both of these extremes are
mitigated by the hybrid treatment: faster treatment reduces protein denaturation and
presaturation with water prevents matrix dehydration. However, the hybrid treatment
does cause a significant decrease in MOEelastin, though the decrease is less dramatic than
that caused by the standard SDS treatment.
It should be noted that the uniaxial ring test has some limitations. First, a uniaxial
test does not accurately represent the stresses applied to blood vessels in vivo, as those
stresses are biaxial and vary with time and blood pressure. Additionally, blood vessels
are highly anisotropic, so using globalized values of stretch ratio and strain can introduce
error for specific locations on the specimen, especially those near the clamps on each end.
A more robust approach would include biaxial testing with monitoring of local stresses
and strains using a digital camera or other imaging device, as others have demonstrated.
[222, 223].
Removal of SDS is another consideration for scaffold viability, as cytotoxicity is
observed for many cell types at concentrations greater than about 0.002% SDS [164].
Residual SDS was quantified for the standard SDS treatment and the SDS/scCO2 hybrid
treatment, Figure 6.10. The figure shows that one hour of scCO2 treatment removes
about as much SDS as 24 hours of washing with PBS, a significant time savings. PBS
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Table 6.2 – Elastic Moduli for Uniaxial Ring Tests
Treatment
Untreated
SDS w/ PBS Wash (S)
scCO2 + ethanol (C)
SDS/scCO2 Hybrid (H)

MOEElastin (kPa)
350.8 ± 18.8
106.2 ± 24.2**
715.0 ± 61.9**
232.4 ± 59.5*

*p < 0.05 compared to native aorta
**p < 0.01 compared to native aorta
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MOECollagen (kPa)
717.1 ± 49.3
306.0 ± 23.5**
988.3 ± 50.6**
743.4 ± 49.5

Figure 6.10 – SDS Quantitation Assay: SDS was quantified before and after washing
with either PBS or scCO2. 1 hour of scCO2 treatment compares similarly to 24 hours of
PBS washing, though neither reduces SDS concentration below the cytotoxic level of
0.002%.
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washes also have diminishing returns, making the wash step last several days in many
protocols to reduce SDS below cytotoxic levels [224]. Thus, scCO2 could compare even
more favorably over longer time periods. This finding also indicates some solubility of
SDS in the scCO2 treatment solution; solubility may be low because SDS a charged
molecule, but SDS does have similar molecular weight to other molecules extracted by
scCO2 in this dissertation, such as glutaraldehyde and Ls-54.

6.4

Conclusions
A novel scCO2 method for decellularizing porcine aorta without compromising its

hydration state. This method offers considerably faster decellularization of tissues
without requiring long-term exposure to detergents or organic solvents. As anticipated,
nonpolar scCO2 solutions were proven ineffective for decellularizing porcine aorta by
both histology and DNA quantitation, though presaturating scCO2 with water did better
maintain the hydration state of the matrix, even in the presence of other additives. More
surprisingly, the addition of ethanol to increase scCO2 polarity did not substantially
intensify the extent of decellularization, suggesting that scCO2 alone is unable to lyse the
cell membrane and that the previously proposed mechanism of whole-cell extraction is
unlikely to be valid.
The inability of scCO2 alone is unable to disrupt cell membranes was further
tested by the development of a hybrid decellularization protocol that utilized an SDS
pretreatment step before washing with scCO2 and water plus ethanol as additives. This
treatment shows that scCO2 can extract intracellular material if the cell membrane is
lysed beforehand. Complete decellularization was achieved using this method, which
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was about 24 hr faster than the standard method and maintained the hydration state of the
native tissue. Mechanical response of ECM decellularized by the hybrid treatment was
similar to that of the native tissue, and most residual SDS was removed. Still, further
study is required to determine the capabilities and limitations of this method and to fully
assess the effects of decellularization on the mechanical and biochemical properties of the
matrix.
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Chapter 7

Final Conclusions and Future Perspectives

Natural biomaterials present several advantages as TE scaffold materials.
However, fabricating safe and effective biomimetic scaffolds challenging, and novel
methods continue to seek improvements in functionality, safety, and fabrication
efficiency. Though scCO2 is commonplace in synthetic TE, its use in the fabrication of
naturally-derived TE scaffolds, including collagen and decellularized ECM, is still in its
infancy. More research and development is required before the technologies presented in
this dissertation become clinically viable or can be directly used for other practical
applications. In this brief chapter, some recommended avenues of future research are
discussed.
In Chapter 3, biochemical compatibility was demonstrated between type I
collagen and scCO2 on both a chemical and physical level. This discovery is a gateway
for numerous practical applications going forward. For example, in Chapter 4, scCO2
was used as a crosslinking aid to remove residual glutaraldehyde from collagen films,
avoiding the undesirable long treatment times and high temperature exposure normally
required to remove unreacted glutaraldehyde. Future research should include assessment
of bioactivity, removal of other crosslinking agents, treatment of other types of collagen
(type II, type III, etc.), and also to three-dimensional collagen constructs, as the
morphologies explored in this dissertation, collagen fibers and films, are relatively
simplistic. Many other applications are possible beyond crosslinking, such as scaffold
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fabrication and sterilization with scCO2; some preliminary research exists on the latter
[96, 225].
scCO2 was also explored as a novel decellularization agent. Though previouslyreported tissue dehydration was prevented using a novel presaturation method presented
in Chapter 5, studies in Chapter 6 showed that scCO2 alone is ineffective for
decellularization. Based on evidence that scCO2 is unable to penetrate the cell
membrane, a hybrid treatment was designed using SDS to first lyse cell membranes
followed by scCO2 extraction of intracellular debris. Complete decellularization of
porcine aorta was achieved with the hybrid method. Furthermore, the hybrid method was
faster than the standard method and did not compromise mechanical properties or deposit
large amounts of residual SDS.
These results are exciting, but much more study is still needed. The logical next
step for this work is a factorial design on the parameters of the hybrid method (e.g. SDS
concentration and treatment time, scCO2 pressure, treatment time, and depressurization
rate). This would elucidate which parameters are critical for successful decellularization
and allow the process to be optimized for faster treatment or tuning of specific scaffold
properties. Moving forward, it is imperative to verify scaffold bioactivity after scCO2
treatment. Bioactivity can be studied with an in vitro cell assay, such as Alamar blue or
MTT. More scaffold characterization should also be performed, including more robust
biaxial mechanical testing and electron microscopy, which can determine the effect of
scCO2 decellularization on surface properties and elastic fiber alignment. Finally,
recellularization and in vivo study using an animal model is required to determine the
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efficacy of this decellularization method for clinical TE use. Once the hybrid method is
better understood, this technology can be extended to tissues other than blood vessels.
Additionally, scCO2 should be investigated further regarding ECM sterilization.
Xenogeneic scaffolds were recently classified as medical devices by the US Food and
Drug Administration and therefore require terminal sterilization prior to clinical use
[106]. Research on the effects of sterilization methods on ECM scaffolds has only
recently begun [226], but scCO2 sterilization has been proven effective in this application
and may offer several advantages over other methods [13, 30, 38, 39]. The ultimate prize
for this research is an effective scCO2-based decellularization process that simultaneously
sterilizes; such a process would greatly improve scaffold fabrication efficiency by
eliminating an entire processing step.
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Appendix A: Supplemental DSC Data

Figure A.1 – DSC Thermogram for 25°C Liquid CO2 Treatment: This response is much
more similar to collagen after scCO2 treatment, indicating the effect of treatment
temperature on collagen denaturation when treated with liquid CO2. Noise in the
thermogram resulted from the baseline scan.
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Appendix B: Additional Circular Dichroism Data

Figure B.1 – CD Spectra of Native and Treated Collagen, 10 μg/mL: Positive peak
observed at 225 nm and negative peak at 205 nm. As the concentration increases, the
magnitude of each peak does as well.
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Figure B.2 – CD Spectra of Native and Treated Collagen, 20 μg/mL: No peaks are
observed because the protein is completely unfolded and no longer has secondary
structure.
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Appendix C: Characterization of scCO2 -Treated Aortas
Photographs and mass measurements were taken to analyze gross changes in
appearance or weight caused by detergent and/or scCO2 treatment. Photographs of aorta
specimens after each treatment can be viewed in Figure C.1. One can see obvious
evidence of discoloration when dry CO2 (b) or CO2/ethanol (d) is used, which is likely a
direct result of tissue dehydration. When water presaturation is employed (c, e, and f),
the color change is much less pronounced.
Changes in mass can are listed in Table C.1. These results complement the
photography and histology as well, with water presaturation treatments maintaining most
of the mass (88-95%) while ethanol alone and dry scCO2 (to a much lesser extent)
dehydrate the tissue. These findings make sense based on our past work on presaturation
and tissue dehydration: one would expect water-presaturated scCO2 to not disturb water
in the tissues, dry scCO2 to extract to some water based on the solubility of water in
scCO2, and an ethanol-scCO2 mixture to extract the most water because of the increased
polarity compared to dry scCO2.
Scanning electron microscopy (SEM) was performed to determine if scCO2
treatment disrupted the endothelium or three-dimensional ECM ultrastructure. SEM was
performed for untreated aorta and for treatments A and C. Micrographs of the
endothelial surface can be viewed in Figure C.2. It is clear that treatment C, with ethanol
alone as the additive, is more disruptive to the aorta surface, and that adding water
prevents some of the damage.
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Figure C.1 – Visual Appearance of Aorta Samples: (a) Untreated, (b) Dry CO2 treatment,
(c) Water/scCO2 treatment, (d) Ethanol/scCO2 treatment, (e) Water/Ethanol/scCO2
treatment, (f) Water/Ls-54/scCO2 treatment
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Table C.1 – Changes in Tissue Mass During scCO2 Decellularization
Treatment

Starting Mass (mg)

Final Mass (mg)

% Mass Retained

Dry CO2

372.4

271.0

72.8

A (CO2 + Water)

250.1

238.7

95.4

B (CO2/H2O/Ls-54)

284.6

245.1

86.1

C (CO2 + EtOH)

273.7

84.4

30.9

D (CO2/H2O/EtOH)

245.6

216.7

88.2
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Figure C.2 – Endothelium SEM: SEM micrographs of the endothelium for (a) untreated
aorta, (b) CO2/ethanol-treated aorta, and (c) CO2/ethanol/water-treated aorta.
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A look at the cross-sections of ethanol-treated and water/ethanol-treated aorta is
shown in Figure C.3. Here, it is clear that ethanol treatment disrupts the elastic fibers
much more than when water is employed as an additive; Figure C.3a shows a tangled
mass of different size fibers, while Figure C.3b shows a much more uniform fiber
structure, both in terms of size and alignment; the latter is much more like the crosssection of the native aorta [227]. This confirms histological observations (Figures 6.3
and 6.5) that preventing dehydration by using water as an additive also helps preserve
matrix ultrastructure.
It is should also be noted that it is inappropriate to look for cells in this
circumstance because of the much larger magnification used in electron microscopy
compared to light microscopy. SEM is primarily concerned with surface structure and
physical properties. Additionally, the value of SEM is limited in this study because
biological samples must be dehydrated before viewing for the method to work properly.
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Figure C.3 – Cross-sectional SEM: SEM micrographs of the endothelium for (a)
CO2/ethanol-treated aorta, and b CO2/ethanol/water-treated aorta.
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